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Nanoparticles are essential materials in modern technology due to their unique 
properties, compatibility with biological systems and wide application 
particularly in biomedical applications. Silver nanoparticles (Ag-NPs) have been 
used extensively due to their different characteristics such as surface plasmon 
resonance, chemical stability, and antimicrobial activity. Antimicrobial 
resistance (AMR) has increased due to the misuse of antibiotics particularly in 
developing and undeveloped countries where there are no proper dispensing 
criteria. Bacteria have acquired resistance genes, rendering most antibiotics 
ineffective especially in immunocompromised patients. Silver nanoparticles 
may present a favourable alternative in combating bacteria resistant to 
antibiotics.  Biological synthesis has been identified as the most suitable 
approach for nanoparticle synthesis as it provides control over size, shape, 
distribution and is cost effective in contrast to chemical and physical 
approaches. The study aimed to optimise reaction parameters for synthesis of 
biological Ag-NPs using Enterobacter xiangfangensis Pb204 and determine 
their antimicrobial activity against eight common human pathogens known to 
contaminate water sources. A cell-free extract from an overnight culture of E. 
xiangfangensis Pb204 was added to 1 mM AgNO3 for Ag-NPs synthesis. 
Reaction pH (3, 5, 7 and 9), temperature (25 °C, 30 °C and 37 °C) and time (24 
and 48 h) were evaluated during the synthesis of Ag-NPs which were 
characterised with the use of transmission electron microscopy (TEM) and 
energy dispersive x-ray (EDX) analysis. Silver nanoparticles obtained under pH 
3, 5 and 9 had shape and size variation and were highly agglomerated which 
may affect their antimicrobial activity compared to Ag-NPs obtained under pH 
7. Temperature and reaction time influenced the size, quantity of nanoparticles 
and reduction rate of metal ions into nanoparticles. It was then established that 
nanoparticles produced under the optimum conditions of pH 7, temperature of 
37 °C and 24 hours incubation were stable, small, uniform-sized, spherical and 
well distributed. Six antibiotics (meropenem, ampicillin, cloxacillin, 
ciprofloxacin, vancomycin and combination-type penicillin amoxicillin and 
clavulanic acid) were tested in triplicate using the Kirby-Bauer method against 
the 8 bacterial strains for 24 and 48 hours at 35 ⁰C after which zones of inhibition 
were measured. The isolates were classified as susceptible (S), intermediate 
(I) or resistant (R) according to the Clinical and Laboratory Standards Institute 
(CLSI). Growth inhibition was strain dependent for some antibiotics whereas 
the antibiotic cloxacillin was ineffective on all eight strains. Ciprofloxacin was 
the most effective antibiotic showing activity on seven out of the eight strains 
tested at 5 µg dosage. The antimicrobial activity of the Ag-NPs with an average 
size of 16.7 ± 9 nm was also evaluated against the bacterial strains. The 
nanoparticles were diluted to a final concentration of 0.1 mM (10.8 µg/ml), 0.25 
mM (27 µg/ml), 0.5 mM (53.9 µg/ml) and 1.0 mM (107.85 µg/ml) per well and 
incubated with bacterial culture in Luria Bertani (LB) broth for 24 hours at 35 
⁰C. Growth was monitored in duplicate by measuring the absorbance at 600 nm 
using an xMark Microplate spectrophotometer. Silver nanoparticles at 0.1 and 
0.25 mM concentrations were unable to inhibit the growth of the bacteria as 
compared to those at 0.5 and 1.0 mM concentrations which were bacteriostatic. 
Silver nanoparticles were more effective in preventing growth of E. faecium, A. 




compared to the highest dosage of antibiotic for which each strain was 
susceptible to. The minimum concentration of Ag-NPs required to inhibit 
microbial growth is higher when compared to other studies. However, the dose 
is lower when compared to the antibiotics which were also strain dependent. 
The study had some limitations in terms of the methodologies which may have 
influenced the outcomes such as nanoparticle yield and  uniformity, 
antimicrobial properties and a true comparison of Ag-NPs versus antibiotics. 
Further studies should be done to explore Ag-NPs as an alternative treatment 
for infections including a combination of Ag-NPs and antibiotics which may yield 
better results. 
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Chapter 1 outlines the introduction of the study briefly, covering the focal area 
of the research and highlighting the problem statement and the aim and 
objectives. 
 
Chapter 2 covers the in depth review of relevant literature concerning the 
impacts of antimicrobial resistance (AMR) and a discussion on the use of 
biological Ag-NPs as an alternative treatment to combat the problems 
associated with AMR. 
 
Chapter 3 describes the optimization of synthesis parameters to achieve small 
spherical Ag-NPs specifically referring to pH, temperature and reaction time. 
 
Chapter 4 entails the antimicrobial profiles of Ag-NPs and antibiotics at low 
dosages on eight clinical pathogens which includes six ESKAPE pathogens. 
Comparisons are made to determine which antimicrobials are more effective 
based on the results obtained from the study. 
 
Chapter 5 summarizes the research findings while drawing suitable 





Chapter 1: Introduction 
1.1 Background 
Rickerby and Morrison (2006) reported the influence of nanoscience and 
nanotechnology towards sustainable development in the future, mainly 
affecting industries such as agri-food, healthcare, transport and energy, 
materials, and information and communications technologies.  This is because 
many sectors depend on fossil fuels for energy and transport which their by-
products and waste from manufacturers negatively affect the environment 
leading to damage of the ecosystems (Rickerby and Morrison, 2006). Almost 
10 years later, Iravani (2014), reported that nanoscience and nanotechnology 
has gained much interest considerably because of the effect they may have on 
numerous science areas including pharmaceutical industries, energy, 
electronics and medicine. Nanoscience and nanotechnology account for nano-
sized structures and materials of less than 100 nm. Manufacturing of 
nanomaterials with potentially unique and size-related physico-chemical 
properties highly different from large materials has made nanotechnology grow 
rapidly (Tran et al., 2013). Nanomaterial based technologies have been utilized 
in various areas from medicine to chemistry because shape, size and 
composition of metal nanomaterials are closely linked to physical, chemical and 
optical properties (Millstone et al., 2009; Lee et al., 2012; Lee et al., 2018). 
 
Recent research has been focusing on the biological synthesis of metal 
nanomaterials which makes use of biodegradable materials, moving away from 
traditional chemical methods employing toxic chemicals. Biosynthesis methods 
for nanomaterials are considered to be environmentally friendly and feasible in 
terms of costs. This is because they are rooted on green chemistry principles 
and they can easily be augmented for large production (Mohanpuria et al., 
2007; Iravani 2011; Prabhu and Poulose 2012). Whilst the use of chemical and 
physical methods is more popular in nanoparticle synthesis, using toxic 
chemicals limits their biomedical applications, particularly in clinical fields (Li et 
al., 2011). Applications of metal nanoparticles are common in biosensing, 
biological and biomedical fields with an interest to develop more eco-friendly 
synthesis methods (Park et al., 2015). Metal nanoparticles include gold, silver, 
platinum, palladium, quantum dots, magnetite and uraninite to mention a few. 
Biological synthesis of such metal nanoparticles using bacteria, yeasts, fungi, 
actinomycetes and viruses has been reviewed by numerous studies 
(Narayanan and Sakthivel, 2010). 
 
Ahmad and co-workers (2003) extracellularly synthesized monodispersed and 
spherical gold nanoparticles (AuNPs) of 8 nm (average size) using the 
actinomycete, Thermomonospora sp. Kowshik et al. (2002) produced 
extracellular silver nanoparticles (Ag-NPs) by a silver tolerant strain of yeast 
MKY3, which synthesized 2 – 5 nm hexagonal Ag-NPs in a log phase of growth. 
Predominantly, fungi are considered to be the extracellular nanoparticle 




elements that plays a role during the reduction and capping of nanoparticles 
(Narayanan and Sakthivel, 2010). In another study, it was observed that 
Colletotrichum sp., an endophytic fungus isolated from the leaves of geranium 
plant (Pelargonium graveolens)  rapidly reduces gold ions to zero-valent AuNPs 
(Shankar et al., 2003). 
 
Bacteria are able to synthesize nanoparticles intracellularly or extracellularly 
with good morphology. In the intracellular technique, ions are transported into 
the cell for nanoparticle formation in the presence of enzymes (Li et al., 2011), 
while in the extracellular method, metal ions are trapped on the surface of the 
cells and reduced in the presence of enzymes (Zhang et al., 2011). Extracellular 
production of metal nanoparticles take place when the reduction process of the 
metal ion involves the cell wall reductive or soluble secreted enzymes 
(Narayanan and Sakthivel, 2010). Industrial applications favour extracellular 
nanoparticles compared to those produced intracellularly. This may be due to 
the supplementary processes (ultrasound treatment or reaction with suitable 
detergents) required for intracellular nanoparticles release (Narayanan and 
Sakthivel, 2010). Considerably, bacteria may become biofactories for synthesis 
of nanoparticles such as gold, silver, platinum, titanium, cadmium sulphite etc. 
(Iravani, 2014).  
 
Many studies have investigated Ag-NPs widely because they possess great 
chemical, physical as well as biological characteristics including inherent 
superiority which stems mainly from the size, shape, composition, crystallinity 
and structure of Ag-NPs compared to their bulk form (Sun and Xia, 2002; Kumar 
et al., 2008; Atwater and Polman, 2010; Desireddy et al., 2013; Syafiuddin et 
al., 2017). These particles also possess a high electrical and chemical stability, 
surface-enhanced Raman scattering (SERS) and non-linear optical behaviour 
(Krutyakov et al., 2008). Similar to their bulk counterpart, Ag-NPs are effective 
antimicrobial agents against Gram-negative and Gram-positive bacteria (Durán 
et al., 2005), including extremely multi-resistant strains such as methicillin 
resistant Staphylococcus aureus (MRSA) (Nanda and Saravanan, 2009). 
 
Silver has been used widely in preparation of various antimicrobial agents for 
the past few years because it possesses antimicrobial activity (Klapiszewski et 
al., 2015; Xia et al., 2016) Today it is used to produce Ag-NPs for different 
applications in the fields of medicine, food, health care, etc. (Huang et al., 
2019). Effects of silver ions and Ag-NPs have been shown to be bacteriostatic 
and/or bactericidal against strains such as E. coli, S. aureus including yeast 
(Keat et al., 2015).  However, Méndez-Vilas (2011) reported that complexes 
formation for silver ions is limited while the silver ions effect remain briefly. 
Nonetheless, Mohammed (2015), indicated that the application of Ag-NPs 
which possess novel antibacterial effects by generating reactive oxygen 
species (ROS) such as hydrogen peroxide has resolved this drawback. Studies 




Gram-negative bacteria (including highly resistant bacteria) in contrast to 
Gram-positive bacteria (Shrivastava et al., 2007; Singh et al., 2008). 
 
Some of the antimicrobial activities of Ag-NPs are listed here considering their 
biocidal effectiveness against a large number of microorganisms. The 
antifungal effects of Ag-NPs on Candida albicans involves disrupting the cell 
membrane structure leading to inhibition of reproduction (Kim et al., 2009). Wan 
et al. (2019), studied the Ag-NPs effect on Kaposi’s sarcoma-associated 
herpesvirus (KSHV) and Epstein-Barr Virus (EBV)-associated tumour cells in 
vitro and in vivo. They discovered that for the first time Ag-NPs presented 
exclusively higher cytotoxicity on KSHV/EBV-latently infected cells through 
reactivating viral lytic replication, and that further blocking KSHV primary 
infection via direct termination of the virion particles. Silver nanoparticles could 
serve as an alternative treatment of infectious disease due to the rising 
antibiotic and antimicrobial resistance (AMR) by disease-causing organisms.  
 
Antibiotic discovery and their development in diseases treatment is regarded 
as the greatest achievement in the history of drug development (Peterson and 
Kaur, 2018). However, antibacterial drugs have been overused globally over 
the past decades and the misuse of these drugs in both humans and food-
producing animals have led to the increase in bacterial resistance (WHO, 
2014). The development and extensive use of antibiotics has helped prolong 
the lives of billions of people.  However, the frequent use of antibiotics presents 
accelerated development of resistance by bacteria to these antibiotics, making 
treatment of infections a much more difficult task (Pramanik, 2016). The total 
global consumption of antibiotics was reported to have  increase by more than 
30%, roughly from 50 billion to 70 billion standard units (SU) between 2000 and 
2010 (Pramanik, 2016). Naveed et al., (2015) reported that the misuse of 
antibiotics commonly occurs in cases of diarrheal illnesses and respiratory 
diseases. This practice is common in developing countries (Tzialla et al., 2012) 
where antibiotics are purchased without a prescription (Naveed et al., 2015). 
Antimicrobial resistance has become a major problem in both medical and 
public health due to its direct association with disease management 
(Ramamurthy, 2008).  
 
The increase in antibiotic resistance particularly in hospitals has been noticed 
since early 1960s and currently regarded as a critical threat to health care with 
high mortality rates including health care costs (Pramanik, 2016). Reduced 
efficacy of several disease treatment drugs including antibacterial and antiviral 
drugs due to AMR results in difficulties in disease treatment, high cost, or even 
impossible to treat diseases. The impact of which is most obvious in particularly 
vulnerable patients, leading to prolonged illness and higher mortality rates 
(WHO, 2014). The United States (US) health care has been reported to exhaust 
approximately $21 – $34 billion annually, along with more than 8 million extra 
days in hospital (WHO, 2014). The European Centre for Disease Prevention 




last decade for direct infections cost arising from some of the most important 
antimicrobial resistant bacteria in the European Union (EU), Iceland and 
Norway (ECDC/EMEA, 2009).  There is an excessive use of antibiotics in high-
income countries and therefore they should reduce antibiotic consumption for 
both humans and animals (Antoñanzas and Goossens, 2019).  
 
One of the present critical risk factors is that clinically important bacteria are not 
characterized by resistance to a single antibiotic only but by resistance to 
multiple antibiotics too (Carey and Cryan, 2003). The development of multi-drug 
resistant (MDR) and extremely-drug resistant (XDR) strains is a critical concern, 
resulting in few options to treat such resistance carrying infectious pathogens 
(Peterson and Kaur, 2018). These strains are superbugs arising from common 
human bacteria, having developed resistance and therefore increased 
virulence. They include MRSA and vancomycin resistant enterococci (VRE) 
strains, or opportunistic environmental bacteria which are intrinsically resistant 
such as Pseudomonas aeruginosa and Acinetobacter baumannii (Wright, 2007; 
Miller et al., 2014).  
 
Peterson and Kaur (2018) stated that it is natural for microorganisms producing 
antibiotics to also produce defence mechanisms for protection against their own 
antibiotics. Furthermore, it is believed that cohabitation of antibiotic-producing 
and non-producing bacteria is among the causes of co-evolution of resistance 
mechanisms in non-antibiotic-producing environment. There are other 
organisms which do not produce antibiotics, yet they carry degradation 
enzymes and vice versa (Peterson and Kaur, 2018). These are some of the 
factors that lead to the increasing spread of antibiotic resistance by most 
species which is a concern leading to the need for new methods to treat 
antimicrobial resistant strains. 
 
1.2 Problem statement 
Many water pathogens are becoming drug-resistant due to the misuse of 
antibiotics and accelerated development of self-resistance mechanisms. 
Antibiotic resistant bacteria and their genes have been detected in several 
water sources including tap and bottled water (Wang et al., 2016), untreated 
wells (Zhang, H. et al., 2015; Zhang, T. et al., 2015) as well as rivers and lakes 
(Jiang et al., 2013). Antibiotic presence in rivers and lakes which results in 
antibiotic resistance development, complicates management of these water 
systems (Schwartz et al., 2003). This is because the systems are primary water 
sources used widely for drinking water (Xi et al., 2009), irrigation and 
recreational purposes (Liu et al., 2018). Processes used to treat drinking water 
are frequently not formulated to eliminate antibiotic resistance (Sanganyado 
and Gwenzi, 2019). Furthermore, they may even aid the emergence, 
distribution and channelling of antibiotic resistance bacteria from the 






The deterioration of water quality and development of antibiotic resistant 
bacteria and presence of their genes in African rivers results from large disposal 
of urban wastewater effluents into the rivers (Sibanda et al., 2015). Several 
technologies such as membrane filtration, advanced oxidation processes and 
nanotechnology were established and currently being used to treat drinking 
water (Sanganyado and Gwenzi, 2019). Silver nanoparticles could present a 
favourable alternative to treat several common bacterial infections. The present 
study anticipates that Ag-NPs produced by Enterobacter xiangfangensis Pb204 
will exhibit antimicrobial effects against common water pathogens namely, 
Enterococcus faecium, S. aureus, A. baumannii, Klebsiella pneumoniae, P. 
aeruginosa, E. cloacae, E. coli and Vibrio cholerae at a dosage lower than that 
commonly used in antibiotics. 
 
The bacteria E. xiangfangensis was isolated from acid mine decant produced 
by a uranium mine in the West Rand, Gauteng (26°06'26.8"S 27°43'20.2"E). It 
was identified as an isolate of Enterobacter sp. by 16S rRNA and was assigned 
to identity Enterobacter sp. Pb204, then later Enterobacter xiangfangensis (Ho 
et al., 2018). A study by Vallabh (2016) demonstrated resistance of the 
bacterium to lead (Pb), cobalt (Co), manganese (Mn), zinc (Zn) and nickel (Ni). 
Furthermore, synthesis of Ag-NPs by E. xiangfangensis was reported (Hiebner, 
2016). The presence of an integrative and conjugated elements (ICEs) 
containing genes coding for proteins involved in resistance to several heavy 
metals including silver was revealed by whole genome sequencing of the 
bacterium. The proteins involved in silver resistance include those in the 
complete sil operon: silE, R, C, F, S, B and A as well as copG (Ho et al., 2018) 
further confirming the link between silver resistance and Ag-NP synthesis of the 
Enterobacter sp. 
 
1.3 Aim and objectives 
 
1.3.1 Study aim 
This study set out to compare the antimicrobial activity of biogenic silver 
nanoparticles to that of antibiotics used to treat common human pathogens 
that contaminate water and include the ESKAPE group of pathogens. 
 
1.3.2 Objectives  
To achieve this aim, the following objectives were outlined: 
• To synthesize Ag-NPs using the cell free extract of E. xiangfangensis 
Pb204. 
• To characterize Ag-NPs using transmission electron microscopy (TEM) 
in order to determine optimum reaction parameters for biosynthesis 
based on size, shape and distribution. 
• To test the antimicrobial activity of the Ag-NPs and antibiotics against 




• To compare the Ag-NPs antimicrobial profile to that of antibiotics used 
in the present study. 
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Chapter 2: Literature review 
2.1 Emergence of antimicrobial resistance 
Antibiotics are medicinal drugs used to kill or slow down infections caused by 
bacteria. The misuse of antibiotics has resulted in AMR to these drugs by 
microorganisms particularly bacteria. Antibiotic resistance occurs when 
bacteria are able to resist antibiotics effects. The emergence of AMR is a 
serious concern threatening public health, health care cost and mortality. More 
than a hundred thousand deaths are reported annually due to antibiotic 
resistance (Review on Antimicrobial resistance, 2014). The World Health 
Organization (WHO) recognizes antibiotic resistance as a major global threat 
due to its projected increase (WHO, 2014). The struggle against the emerging 
antibiotic resistance has transpired mainly in clinical, community and recently 
spreading to agricultural environment with an aim to alleviate transmission and 
prevent selection of resistant bacteria during antibiotic treatment (Bengtsson-
Palme et al., 2018). The inadequate knowledge on how and under which 
circumstances resistance development is facilitated by the environment, makes 
mitigation of emergence and spreading of mobile resistant factors problematic 
(Berendonk et al., 2015).  
 
Naturally, an organism that can produce antibiotics, should subsequently carry 
mechanisms for resistance against its own antibiotics (Peterson and Kaur, 
2018). Bacteria that produce antibiotics have a variety of sophisticated 
mechanisms for self-resistance and very often they contain more than one 
mechanism at the same time, to ensure that they are completely protected from 
the biologically active modules they produce (Peterson and Kaur, 2018). Drug 
resistance mechanisms fall into a number of wide categories such as 
alteration/inactivation of drugs, drug binding site/target modification, cell 
permeability changes that reduces drug accumulation within the cell, including 
formation of biofilm (Li and Nikaido, 2004; Wright, 2005; Wilson, 2013). The 
main biochemical pathways for self-resistance mechanisms found in antibiotic 
producing organisms are highlighted in figure 2.1; for each a specific example 
is provided. A common method to render antibiotics ineffective is antibiotic 
modification in particularly where aminoglycoside antibiotics, chloramphenicol 






Figure 2.1. Illustration of different mechanisms of antibiotic resistance within 
bacteria presented with examples that include antibiotic modification (A), 
antibiotic degradation (B), efflux of antibiotics (C), target modification of 
antibiotics (D), antibiotic sequestration by special proteins (E) and antibiotic 
target bypass (F) (Peterson and Kaur, 2018). 
 
There are species which do not generate antibiotics, however, they carry 
modification enzymes for resistance and vice versa. Streptomycin resistance is 
excluded from this because it has been established that antibiotic synthesis is 
correlated to the role of modification enzymes in self-resistance (Peterson and 
Kaur, 2018). Streptomycin 6-phosphotransferase is a modification enzyme that 
functions to convert streptomycin to inactive precursor streptomycin-6-
phosphate in the producer Streptomyces griseus (Peterson and Kaur, 2018). 
 
Antibiotic efflux usually works in combination with other resistance mechanisms 
such as antibiotic modification of the target. Streptomyces peucetius is an 
example of an antibiotic producer involved in antibiotic efflux. The organism 
produces daunorubicin (Dnr) and doxorubicin (Dox) anticancer antibiotics 
which are closely related and the two intercalate with DNA to avert further 
replication rounds (Peterson and Kaur, 2018). Efflux of these antibiotics in S. 
peucetius occurs by an ATP Binding Cassette (ABC) family transporter DrrAB 
coded by drrAB genes embedded within the genes responsible for 





Sequestration involves drug-binding proteins which supresses antibiotics from 
reaching their target. The metal bound or metal-free antibiotic sequestration is 
involved in the primary resistance mechanism in the bleomycin family of 
antibiotic producers (Sugiyama and Kumagai, 2002). One or more genes of 
each of the bleomycin family producer is associated with ABC transporters in 
their biosynthesis cluster (Du et al., 2000; Tao et al., 2007; Galm et al., 2009), 
capable of being applied for removal of the antibiotics bound to binding proteins. 
 
Target modification functions as a mechanism of self-resistance against various 
antibiotic classes such as aminoglycosides, β-lactams, macrolides, 
lincosamides and streptogramins (MLS) (Peterson and Kaur, 2018). Target 
modification utilizes 16S rRNA methyltransferases for resistance against 
aminoglycosides in which methylation occurs at A1408 or G1405 residues 
(Shakil et al., 2007). The structure of β-lactam antibiotic enables the association 
and acylation of the active site serine by the antibiotic which results in its 
inhibition (Yeats et al., 2002). 
 
Prevalent and haphazard antibiotics use since the discovery of antibiotics gave 
rise to resistant strains for all antibiotics that have been discovered to date. 
These observations anticipate that there may soon be development of resistant 
strains from all antibiotic used or in the long run. The spontaneous mutations 
rate also contributes to the emerging antibiotic resistance and extensively 
continuous exchange of DNA mechanisms in bacteria (Peterson and Kaur, 
2018). One of the growing concerns in public health is the ESKAPE pathogens 
that comprise a group of bacteria with rapidly increasing MDR. Antimicrobial 
resistance in these organisms are expected to increase before long due to 
continuous changes in resistance profiles, resulting in the death of potential 
pipeline therapeutic agents (Santajit and Indrawattana, 2016). 
 
2.2 Antibiotic resistance in ESKAPE pathogens 
ESKAPE pathogens are among the world’s leading cause of infections 
associated with health care (Santajit and Indrawattana, 2016), especially in 
critically ill and immunocompromised individuals (Zhen et al., 2019). The 
ESKAPE acronym is derived from bacteria primarily responsible for most 
antibiotic resistance namely; E. faecium, S. aureus, K. pneumoniae, A. 
baumannii, P. aeruginosa and Enterobacter species, with the first two being 
classified as Gram-positive bacteria followed by four Gram-negative bacteria. 
These are among the most common bacterial species in health-care acquired 
infections, threatening human health and becoming more resistant to antibiotics 
commonly used (Zhen et al., 2019). Consequently, these pathogens are 
associated with the rising morbidity and mortality rates, accelerated healthcare 
costs and uncertainties of diagnostics leading to further doubts in traditional 
medicine (Santajit and Indrawattana, 2016). The focus of attention towards 
ESKAPE organisms can help in tackling the wide challenge of antibiotic 




the resistance mechanisms that each ESKAPE pathogen uses to render 
antibiotics ineffective. 
 
Table 2.1. Examples of ineffective antibiotics and the mechanisms of antibiotic 
resistance in ESKAPE pathogens. 
Resistant 
strain 


































































Carbapenems  Peterson and Kaur, 
(2018) 
Tiwari et al. (2020) 
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aeruginosa 
Gram − Fluoroquinolones 
Imipenem 
Carbapenem  

























Peterson and Kaur, 
(2018) 
 
Mutations and acquisition of mobile genetic elements are known to cause 
resistance development in E. coli (WHO, 2014). Fluoroquinolone resistance is 
mostly attributed to mutation while acquisition of mobile genetic elements has 
been the case for broad-spectrum penicillins and resistance to third-generation 
cephalosporins (WHO, 2014). Nosocomial infections by MDR extended-
spectrum β-lactamase (ESBL)-producing E. coli pose a serious health risk in 
hospital settings (Mehrad et al., 2015). Pathogenic E. coli is has the capacity to 
cause a number of humans infections including diarrhoea, peritonitis, urinary 
tract infections (UTIs), bacteremia and colitis (Makvana and Krivol, 2015). In a 
case of resistant strains, carbapenems are usually used for treatment because 





The ability of A. baumannii to develop into an MDR strain has enabled it to 
become an increasing threat to hospital patients. A combination of mechanisms 
including expression of β-lactamases, alteration of cell membrane permeability 
and increased efflux pumps expression contributes to drug resistance in A. 
baumannii (Zarrilli et al., 2013).  The emergence of carbapenemase-producing 
A. baumannii strains carrying imipenem metallo-β-lactamases and oxacillinase 
serine β-lactamases has been reported recently (Santajit and Indrawattana, 
2016). These strains demonstrated resistance to both colistin, and imipenem 
and the combination of resistance genes gives them the ability to quell the 
action of most traditional antibiotic compounds (Vila et al., 2007; Boucher et al., 
2009).  
 
S. aureus can cause a number of infections, most commonly infections of the 
skin, bone, soft tissue and blood stream, and it is the frequent cause of most 
infections in postoperative wounds (WHO, 2014). Resistance to almost all early 
antibiotic classes (penicillin, amoxicillin and ampicillin) in S. aureus is mediated 
almost exclusively by determinants acquired through horizontal DNA transfer 
(Pantosti et al., 2007). Strains of S. aureus resistant to penicillinase stable 
antibacterial drug, which are referred to as MRSA have acquired a novel gene 
(mecA) that codes for a novel penicillin-binding protein (WHO, 2014). MRSA is 
a major AMR pathogen responsible for a number of diseases throughout the 
world, from mild skin infections to fatal diseases (Loncaric et al., 2019).  
 
K. pneumoniae is the species within which several new genes coding for AMR 
were discovered before spreading to other pathogens (Wyres and Holt, 2018). 
Resistance to several antibacterial drugs arise mainly from horizontal transfer 
of mobile genetic elements such as transposons or plasmids (WHO, 2014). 
Although, the contribution of this strain to the overall AMR challenge cannot be 
quantified, existing research indicates that it has a broader ecological range, 
considerably more varied DNA structure, greater diversity of AMR gene and a 
higher plasmid burden compared to other gram-negative bacteria (Wyres and 
Holt, 2018). Predominantly, K. pneumoniae is responsible for infections caused 
by carbapenem-resistant bacteria worldwide and there are no clinically effective 
treatments for many patients infected with these bacteria (WHO, 2014).  
 
E. faecium is associated with vancomycin resistance. It can cause severe 
morbidity and mortality in immunocompromised hosts (Lee et al., 2019).  
Hypermutable DNA of E. faecium attributes to the rapid adaptation to 
antimicrobials by the strain (Lee et al., 2019). E. faecium strains are able to 
acquire and spread resistance genes swiftly via mobile genetic elements such 
as transposons and plasmids that are present among bacteria (Clewell, 1990). 
Many E. faecium have acquired high level resistance to β-lactam through 
modification of the penicillin-binding protein 5 (PBP5), resulting in decreased β-
lactam affinity, increased tolerance to β-lactam and a combination of the two 
above modifications which can exponentially increase resistance (Fontana et 





P. aeruginosa is a common pathogen in hospital intensive care units (ICUs) 
due to the propensity of its innate resistance to several antibiotics and 
antiseptics, and the ability to accumulate further resistance mechanisms to 
multiple classes of antibiotics (Pachori et al., 2019). Drug resistance in P. 
aeruginosa arises from innate and acquired resistance mechanisms. Innate 
resistance involves presence of over expressed efflux pumps and low 
permeability of outer membrane (Santajit and Indrawattana, 2016), while 
acquired resistance comes about due to the acquisition of resistance genes or 
mutations in porins-encoded genes, penicillin-binding proteins and 
chromosomal β-lactamase (Oie et al., 2009). 
 
A major source of building up, spreading and amplifying drug resistance in 
organisms is ICUs, where there is a higher selection pressure for resistance 
development of drug-resistant pathogens (Esposito and Leone, 2007) because 
of high antibiotics use for infection treatment in patients (Pachori et al., 2019). 
Furthermore, ICU patients are faced with  a higher infection risk because they 
have immunocompromised system, use of multiple procedures, and invasive 
devices such as mechanical ventilation, central venous catheterizations (CVC) 
and urinary tract catheterizations (Ranjan et al., 2014). The variety of resistance 
genes present in the environment indicates that there are a lot more resistance 
genes available for recruitment by pathogens (Bengtsson-Palme et al., 2018). 
In 2017, WHO published a list of bacteria (Pseudomonas species and various 
Enterobacteriaceae including Klebsiella species and E. coli) for which there is 
an urgent need for new antibiotics to treat these pathogens regarded as of 
critical priority (Ortega-Huedo et al., 2020). The report outlined a concern 
regarding resistance of fluoroquinolones and third generation cephalosporins 
(WHO, 2017). 
 
2.3 Economic burden emerging from AMR  
The accelerating AMR affects not only mortality of humans and animals but also 
the cost used to take measures for prevention of diseases and spreading of 
resistance. The AMR economic cost can be described as the increasing cost of 
patient treatment with resistant infections relative to susceptible infections as 
well as the indirect productivity loss because of high mortality resulting from 
resistant infections (Shrestha et al., 2018). One of the driving host factors of 
AMR is human consumption of antimicrobials, implicating different drug classes 
and propagating resistance in different pathogens (Shrestha et al., 2018), which 
in turn affects the cost needed to fight resistance. Coast et al. (1996), argued 
that the omission of antimicrobial costs in economical evaluation was outlined 
partially by its quantification difficulties, with substantial uncertainties related to 
resistance mechanisms, lack and poor relevant data quality, and other 
methodological challenges (Coast et al., 1998; McGowan, 2001). Although 
some studies published have analysed the antibiotic resistance burden on the 




the health sector, patients and society at large has not been measured 
adequately (WHO, 2014).  
 
Shrestha et al. (2018), evaluated the economic cost of AMR of five ESKAPE 
pathogens excluding E. faecium per antibiotic used mainly in Thailand and the 
US. The overall economic AMR cost in the five pathogens due to drug 
resistance was $0.5 billion and $2.8 billion in Thailand and the US respectively. 
The antibiotic cost per SU between the two countries was different for a number 
of reasons. Thailand has a higher AMR burden amounting to 28 deaths 
connected to AMR per 100,000 relative to the US with 4.6 per 100,000. In 
addition, epidemiological profiles of the two countries are different. For 
instance, Thailand is associated with  high burden of mortality that arise from 
Acinetobacter relative to MRSA dominance in the US. In South Africa an 
estimated 450,000 new cases of tuberculosis (TB) were reported in 2014 with 
1.8% of the new cases and 6.7% of the previously treated cases estimated to 
have MDR-TB (National Department of Health (NDoH), 2015). The global 
health expenditure database of WHO (2016), suggests a lack of resources and 
infrastructure in middle- and lower-middle-income countries, making it difficult 
to evaluate the economic impact of AMR in those countries.  
 
Most resistance cases are associated with longer hospitalization periods, 
expensive drug use, increased doctor visits and disabilities (Abushaheen et al., 
2020). The costs per patient total over $20 billion per year in the US health care 
costs (Golka et al., 2014). Two common hospital-acquired infections 
(pneumonia and sepsis) was responsible for almost 50,000 deaths in America 
and cost the US health care system over $8 billion in 2006 (Eber et al., 2010). 
The direct and indirect cost of AMR due to MRSA in Thailand was estimated at 
$29 million and $151 million, respectively (Shrestha et al., 2018). Approximately 
$55 billion in the US is exhausted on antibiotic resistance, where health care 
costs and lost productivity per year account for $20 billion and $35 billion, 
respectively (CDC, 2013). 
 
A substantial quantity of antibiotics is used in South African livestock, including 
numerous antibiotics that have been banned for use in other countries (Eagar 
et al., 2012; Moyane et al., 2013). Antimicrobial use in livestock is estimated to 
increase by 67% in 2030 and nearly double in Brazil, Russia, India, China and 
South Africa (Van Boeckel et al., 2014). If AMR is unchecked, its high costs on 
the population and economy may result in medical poverty trap (Ahmad and 
Khan, 2019). The risk of medical poverty trap is mainly associated with low-
resource areas, exposing vulnerable communities to a generational poverty 
which will increase deaths rate (Ahmad and Khan, 2019). There is an urgent 
need for more research on antimicrobial stewardship including other areas of 
infection prevention besides pure antibiotics medication (Huebner et al., 2019). 
 
Davey et al. (2013) described antimicrobial stewardship as co-ordinated efforts 




reduction of microbial resistance as well as decreasing the spread of multi-drug 
resistant organisms and unnecessary costs. The NDoH in South Africa 
advocated by South African Antibiotic Stewardship Programme (SAASP), 
developed an AMR National Strategy Framework (2014-2024) in response to 
the global strategy of WHO for combating AMR (NDoH, 2014; Mendelson, 
2015). The strategy outlines measures to control AMR, reduce further increases 
in resistant microbial infections and improve patients’ outcomes (NDoH, 2014). 
However, such strategies are not sufficient alone since microbial resistance has 
been shown to evolve and increase whenever new antibiotics are introduced. 
Further alternatives should be explored such as Ag-NPs which are effective 
against numerous microbial agents. Silver nanoparticles are considered as one 
of the effective antimicrobials in various microorganisms including resistant 
pathogens, due to their greater properties (Frattini et al., 2005; Krutyakov et al., 
2008). 
 
2.4 Silver nanoparticles and their properties 
StatNano (2016) reported about 3509 nanotechnology products in many 
sectors including automotive, cosmetics, petroleum, sports and fitness, textiles, 
water and wastewater. Currently Nanotechnology Products Database (NPD, 
https://product.statnano.com) report about 8867 nanotechnology products 
where silver accounts for 942 products. This figure have tripled the number 
reported by Project on Emerging Nanotechnologies (PEN, 
http://www.nanotechproject.org) in 2013 where nanosilver accounted for 313 
products. This can be attributed to competitive properties of Ag-NPs making 
them ideal for industrial application. Silver nanoparticles have distinguished 
physicochemical properties including a high electrical and thermal conductivity, 
chemical stability, SERS, non-linear optical activity and catalytic activity 
(Krutyakov et al., 2008). The fraction of atoms present on the nanoparticles 
surface attributes to these properties which increases their thermodynamic 
stability (Roduner, 2006). The catalytic activity of Ag-NPs depends on their size, 
structure, shape, size distribution and chemical-physical environment (El-Nour 
et al., 2010).  
 
Physicochemical properties also have an effect on the dissolution of Ag-NPs 
and their biodurability (Utembe et al., 2015). The shape of Ag-NPs may have 
an effect on the mechanisms of cellular uptake within the organisms resulting 
in modulation of cytotoxicity (Akter et al., 2018). Aggregation and agglomeration 
properties are major factors in different rates of uptake and stability of 
nanoparticles in the cell (Cho et al., 2011; Gliga et al., 2014; Milić et al., 2015). 
A number of different biological effects (oxidative stress, DNA damage, 
mitochondrial disfunction and permeabilization) across biological barriers are 
mediated by the size Ag-NPs (Riaz-Ahmed et al., 2017). 
 
2.5 Application of Ag-NPs in various industries 
Silver nanoparticles are significantly interesting in modern nanotechnology 




various applications such as catalysis, antiseptic agents (medical sector), food 
packaging, cosmetics, bioengineering and environmental applications (Keat et 
al., 2015). Several accredited institutions including US Food and Drug 
Administration (US FDA), US Environmental Protection Agency (US EPA), 
Society of Industrial-Technology for Antimicrobial Articles (SIAA) of Japan, 
Korea’s Testing and Research institute for Chemical Industry, and FITI Testing 
and Research Institute have approved products made with Ag-NPs (AZoNano, 
2006). Keat et al. (2015) identified a wide range of areas (figure 2.2) where Ag-
NPs can be applied. 
 
               
Figure 2.2. Applications of Ag-NPs in various industrial sectors ranging from 
health care, biomedical and textile industries to food, petroleum and water 
treatment. These include using Ag-NPs as antimicrobials in water treatment, 
antiseptic agents in food packaging and medical industry and catalyst fuel 
industry (Keat et al., 2015). 
 
In water disinfections, processes such as filtration, reverse osmosis, UV-treated 
filters, chlorination and advanced oxidation treatment, are commonly used for 
water treatment. However, they have drawbacks such as high cost (reverse 
osmosis) (Deshmukh et al., 2018), limited activity (filtration) and conjugative 
transfer of antibiotic resistant bacteria (chlorination) (Sharma et al., 2016). On 
the other hand, the use of Ag-NPs in water treatment has gained significant 
attention (Tran et al., 2013). Water filters implanted with Ag-NPs have been 
shown to be efficient in removing and deactivating microbes through the use of 
two methods, metal disinfection and physical filtration (Deshmukh et al., 2018). 




development of smart materials for packaging food. Singh and Sahareen (2017) 
investigated low cost and environmentally friendly packets for vegetables 
storage which were embedded with Ag-NPs. After periodic determination, the 
shelf life of the vegetables was seen to increase while maintaining the nutrition 
value of the vegetables. 
 
Silver nanoparticles are further used in medical application where they are 
impregnated in catheters, cardiovascular and bone implants to hinder biofilm 
formation and minimize pathogenic invasion risk (Tran et al., 2013). Nano-
crystalline dressing for wound therapy or hospital-acquired infections also uses 
Ag-NPs to minimize inflammatory response (Fong and Wood, 2006). Silver 
nanoparticles are preferable in textiles compared to traditional antimicrobial 
agents such as salts, quaternary ammonium compounds and triclosan 
(Deshmukh et al., 2018), due to a number of factors including bactericidal 
resistance, low cost and environmental friendliness (Tamboli et al., 2013; 
Wagener et al., 2016). Generally, Ag-NPs can be considered as an ideal 
candidate for many commercial applications particularly in the biomedical 
industry (Keat et al., 2015). 
 
2.6 Antimicrobial activity of Ag-NPs on bacteria, fungi, yeasts and viruses 
The antimicrobial effects of Ag-NPs are highly reported in various 
microorganisms including a range of bacteria, fungi, yeasts and virus, with high 
success rate of repression. The key mechanisms in antimicrobial activity of Ag-
NPs can be simplified to their high surface area in releasing ions (Lee and Jun, 
2019). Oxidization of Ag-NPs in aqueous environment takes place in the 
presence of oxygen and protons, releasing silver ions as the particle surface 
dissolves (Lee and Jun, 2019). However, the rate at which the ions are released 
is dependent on factors such as capping agent, colloidal state as well as of 
nanoparticle shape and size (Lee and Jun, 2019). For example, Sriram and 
colleagues (2012), demonstrated that small-sized or anisotropic Ag-NPs with a 
larger surface area was more toxic and released ions rapidly due to high 
surface energy emerging from highly curved or strained shape of nanoparticles. 
 
Kim et al. (2007) reported suppression of growth on yeasts and minimum 
inhibitory concentration (MIC) between 6.6 and 13.2 nM. Pařil et al. (2017) 
studied the effects of Ag-NPs and copper nanospheres on wood-rotting fungi 
at a very low mass treatment of the Ag-NPs. Their study displayed highly 
efficient Ag-NPs activity against Tinea versicolor fungi as compared to Poria 
placenta fungi showing distinct antifungal effects of Ag-NPs on white and 
brown-rot fungi. Rajeshkumar et al. (2014) studied the antifungal activity of 
green synthesized Ag-NPs against Fusarium sp. Inhibition zones of 22.03 ± 
0.033 mm in diameter were observed against the Fusarium sp.  
 
Studies have demonstrated  antiviral effects of Ag-NPs in different viruses such 
as human immunodeficiency virus (HIV) (Sun et al., 2005; Lara et al., 2010a, 




et al., 2009, 2010) and influenza virus (Papp et al., 2010). The specific Ag-NPs 
mechanism against specific viral infections may differ. In that regard, the 
potential mechanisms could rely on either interaction with surface glycoproteins 
of the virus, competition for virus binding to the host cells, viral particles 
inactivation before entry or impairing viral double-stranded DNA (Wan et al., 
2019). A study conducted by Lara et al. (2010a) to evaluate the antiviral activity 
of Ag-NPs on HIV-1 at non-cytotoxic concentrations revealed clear anti-HIV 
activity at an early viral replication stage. Silver nanoparticles of 10 nm have 
been reported to inhibit replication of hepatitis B virus (Lu et al., 2008).  
 
The exact mechanism of antimicrobial activity of nanosilver on bacteria is not 
fully understood but three toxicity mechanisms have been proposed. These 
include: (i) free silver ion uptake followed by disruption of ATP production and 
DNA replication, (ii) Ag-NPs and silver ions generation of ROS, and (iii) Ag-NPs 
direct damage to cell membranes (Marambio-Jones and Hoek, 2010). Silver 
nanoparticles have already been proven to exhibit toxic effects on both aerobic 
and anaerobic bacteria isolated from wastewater treatment (Choi and Hu, 
2008). The strength of Ag-NPs effects is different with bacterial species (Lee 
and Jun, 2019) as they differ in structure, thickness and cell wall composition 
(Tamayo et al., 2014). For instance, E. coli is more susceptible to silver ions 
compared to S. aureus due to differences in the thickness of their peptidoglycan 
layer in the cell wall (Lee and Jun, 2019). 
 
Bera et al., (2014) studied the size and shape dependent antimicrobial activity 
of Ag-NPs against P. aeruginosa, S. epidermidis and B. megaterium in which 
the smaller particles were able to penetrate the cell walls and enhance 
antimicrobial activity. In a separate study by Guzman et al. (2012), Ag-NPs 
proved to be effective against E. coli, P. aeruginosa and S. aureus at 
concentrations of 14.38, 6.74 and 14.38 ppm, respectively. Cavassin et al., 
2015) investigated the antimicrobial activity of Ag-NPs (citrate-stabilized, 
chitosan and polyvinyl alcohol PVA) against oxacillin-resistant S. aureus, VRE, 
carbapenem- and polymyxin B-resistant A. baumannii, carbapenem-resistant 
P. aeruginosa and carbapenem-resistant Enterobacteriaceae. Their study 
suggested that citrate and chitosan complexed Ag-NPs are best inhibitors 
against the strains tested. Nanoparticles exhibit great antibacterial effects 
especially in Gram-negative bacteria (Keat et al., 2015). This is because of the 
bacterial cell wall structure which can easily be penetrated. Silver has thus been 
a driving force over the past decades to address the increasing threat of 
antibiotic resistance resulting from the misuse of antibiotics; leading to the 
development of different methods of Ag-NPs production for industrial 
application (Keat et al., 2015). 
 
2.7 Synthesis of Ag-NPs 
2.7.1 Overview of nanoparticle synthesis 
Metal nanoparticles are usually synthesized in either top-down or bottom-up 




nanomaterials in the top-down method, while single atoms and molecules are 
assembled into larger nanostructures to produce nano-sized materials when 
using bottom-up technique (Chugh et al., 2018). Synthesis of Ag-NPs has been 
explored and conducted through various methodologies such as chemical, 
physical and more recently through biological approaches. There are 
advantages and disadvantages associated with each method, common 
problems being costs, scalability, particle size and distribution (Tran et al., 
2013). Furthermore, chemical and physical approaches tend to be more labour-
intensive and hazardous, relative to biological methods which presents 
attractive properties such as high yield, solubility and stability (Zhang et al., 
2018).  While nanoparticle synthesis through chemical and physical methods is 
more popular, the use of toxic chemicals significantly limits their biomedical 
application, particularly in clinical fields (Li et al., 2011). Comparison between 
the chemical, physical and biological methods shows that biological methods 
are favourable because of economic efficiency, reproducibility, simple 
procedures and require less energy.  
 
2.7.2 Chemical methods for Ag-NPs synthesis 
Chemical synthesis of Ag-NPs can be subdivided into chemical reduction 
(Zhang et al., 2011), irradiation-assisted chemical methods (Sotiriou and 
Pratsinis, 2010), electrochemical techniques (Roldán et al., 2013) and pyrolysis 
(Sotiriou et al., 2011). The chemical process usually employs three main 
components namely metal precursors, reducing agents and capping/stabilizing 
agents (Tran et al., 2013). Reducing agents that are widely used include 
ascorbic acid, borohydride, alcohol, sodium citrate and hydrazine compounds 
(Wei et al., 2015). Reducing and capping agents can easily be changed or 
modified to achieve desirable characteristics of Ag-NPs in terms of shape, size 
distribution and rate of dispersion (Pillai and Kamat, 2004). Distinct metallic 
salts are utilized to produce corresponding metal nanomaterials such as gold, 
silver, zinc oxide, copper, platinum, etc. (Kinnear et al., 2017). During synthesis 
of nanoparticles, the strength and type of reducing agents and stabilizers 
should be considered to achieve nanoparticles of a specific size, shape with 
various optical properties. 
 
2.7.3 Physical methods for Ag-NPs synthesis 
Toxic chemicals are not employed in physical methods and processing is faster 
compared to chemical methods. However, high energy consumption is a major 
drawback in physical synthesis (Wei et al., 2015).  The methods usually include 
arc-discharge (Tien et al., 2008), physical vapor condensation (El-Nour et al., 
2010), energy ball milling (Kosmala et al., 2011) and direct current magnetron 
sputtering (Asanithi et al., 2012). The evaporation condensation method is 
capable of synthesizing large quantities of high purity Ag-NPs without the use 
of chemicals that release toxic substance and jeopardize human health and the 
environment (Lee and Jun, 2019).  Agglomeration is often a major drawback in 
the evaporation condensation method because capping agents are not used 
(Lee and Jun, 2019).  Using the arc-discharge method, Tien et al. (2008) 




where silver wires were submerged in the deionized water and used as 
electrodes. Siegel et al. (2012) reported on the synthesis of AuNPs and Ag-
NPs using direct metal sputtering into liquid medium.  
 
2.7.4 Biological methods for Ag-NPs synthesis 
Efforts have been made to utilize microorganisms as potential eco-friendly 
nanofactories for Ag-NPs synthesis (Mukherjee et al., 2001; Ahmad et al., 2003; 
Panáček et al., 2006). Studies have reported that cell free extracts of some 
bacteria such as Bacillus sp., E. coli, E. cloacae, S. aureus, K. pneumoniae, 
Lactobacillus acidophilus and P. aeruginosa could induce Ag-NPs synthesis 
(Shahvredi et al., 2007; Kalimuthu et al., 2008; Saifuddin et al., 2009). Toxic 
reducing agents and stabilizers in biological synthesis are replaced by nontoxic 
molecules such as proteins, carbohydrates and antioxidants (Wei et al., 2015). 
These nontoxic molecules are usually produced by living organisms including 
bacteria, fungi, yeasts and plants. The potential mechanisms of biological 
synthesis include enzymatic reduction such as NADPH reductase and 
nonenzymatic reduction (Ge et al., 2014). Biological agents tend to reduce 
metal ions quicker and at ambient temperature and pressure conditions (Tran 
et al., 2013). 
 
Findings from studies using bacteria to produce Ag-NPs indicate that the size 
and shape of nanoparticles formed varies between species. The reduction of 
Ag+ ions to Ag0 driven by electrons released from NADH in Bacillus 
licheniformis leading to formation of Ag-NPs was demonstrated by Lee and Jun 
(2019). In a separate study, Ag-NPs with a size range of 28.2 – 122 nm 
(average size of 52.5 nm) were produced when a culture supernatant of K. 
pneumoniae was incubated with AgNO3 solution (Shahverdi et al., 2007). Silver 
nanoparticle production also varies between different types of microorganisms. 
Fayaz et al. (2010) studied the use of Trichoderma viride for extracellular 
synthesis of Ag-NPs from AgNO3 solution which resulted in Ag-NPs of 5 – 40 
nm. Silver nanoparticles were synthesized by Aspergillus terreus resulting in 
spherical 8 – 20 nm particles (Balakumaran et al., 2016). The nanoparticles 
exhibited antimicrobial effects against several bacteria including K. 
pneumoniae, P. aeruginosa, S. aureus and E. coli. Other parameters such as 
pH and temperature can influence the size, shape and distribution of 
biosynthesized Ag-NPs as is evident from these studies. 
 
Synthesis of Ag-NPs using biological methods can take place within the cell or 
outside the cell. During the intracellular synthesis, the negatively charged cell 
wall interacts with the positively charged metal ions electrostatically and 
bioreduces the metal ions to nanoparticles (Thakkar et al., 2010). In an 
extracellular synthesis, microorganisms are incubated with silver ions to 
generate Ag-NPs as result of intrinsic defence mechanism against the toxicity 
of the metal (Tran et al., 2013). The mechanism of silver resistance with a focus 





2.7.4.1 Silver resistance in bacteria 
Silver resistance in bacteria has been reported and the resistance mechanisms 
that are encoded by various plasmid-based genes have been studied 
extensively (Silver, 1996; 1998; Silver and Phung, 1996). Microbial resistance 
to almost all toxic heavy metals arise from their chemical detoxification and 
energy-dependent ion efflux from the cell by membrane proteins that function 
either as ATPase or chemiosmotic cation or proton anti-transporters 
(Narayanan and Sakthivel, 2010). Microbial resistance to silver can also be 
affected by alteration in solubility. Therefore, metal ions can be detoxified by 
microbial systems using either reduction and/or precipitation of soluble toxic 
inorganic ions to insoluble non-toxic metal clusters (Narayanan and Sakthivel, 
2010). Nies and Silver (1995) reported that the regulation of intracellular 
concentration of essential metal ions may result from sequestration or by 
changing the oxidation state of the metal ions (for some metals). However, the 
main regulation process for intracellular concentrations of inorganic cations and 
anions is by membrane transport systems. 
 
The presence or absence of a metal ion transporter of certain specificity is 
dependent upon the metal ion, the bacterial species and the physiological state 
of the cell (Nies and Silver, 1995). The bulk metal (Ag0) is relatively nontoxic 
because of poor bioavailability while the silver cation (Ag+) is extremely toxic to 
most microorganisms (Muller, 2018). Bacteria are particularly susceptible to 
Ag+ due to the extreme ability of the cation to pass through the membrane and 
adversely affect metabolic processes by nonspecific mechanisms that include 
binding to DNA, proteins, free thiol groups and interference with enzyme, 
electron transport, and membrane ion-exchange systems (Muller, 2018). The 
current international consensus is that there is relatively slight bacterial 
resistance to silver due to the nonspecific nature of Ag+ toxicity (Chopra, 2007; 
Woods et al., 2009; Elkrewi et al., 2017), although the misuse of silver as an 
antimicrobial agent may lead to more resistance development by 
microorganisms in particular bacteria.  
 
Certain bacterial species have developed the ability to resort to specific defence 
mechanisms to suppress stresses like toxicity of heavy metal ions or metals 
(Iravani, 2014). A study by Gupta et al. (1999), described the gene cluster 
responsible for silver resistance which contains a total of nine genes (silP, 
ORF105, silA, silB, ORF96, silC, silSR and silE). The sil genes have the 
following functions; SilE is responsible for a 143-amino-acid protein that binds 
to metal; silSR is responsible for a membrane sensor kinase and transcriptional 
regulatory responder; silA acts as an antiporter for inner membrane 
cation/proton; silB acts as a membrane fusion that binds outer and inner 
membrane of Gram negative bacteria together; silC functions as an outer 
membrane protein and silP is involved in the heavy metal resistance efflux P-
type ATPase. The function of sil operon was elaborated further by a study 





The study further demonstrated that in strains showing a phenotype of silver 
resistance, there is a prevalence of derepression of transporter expression 
owing to substitution of amino acid within the cognate sensor kinase of CusS 
or SilS. Despite the requirement of derepression of either CusCFBA or SilCFBA 
transporter for silver resistance, the increased efflux of silver that results is not 
sufficient on its own to achieve overt resistance phenotype (Randall et al., 
2015). This was further evident when the possibility of survival by Ag+-sensitive 
microorganisms in Ag+-rich environment was suggested to be far more common 
than currently believed due to achievement of silver resistance without the need 
for mutations or genetic material transfer between bacterial species (Muller and 
Merret, 2014; Muller, 2018). Consequently, relying on the presence of genetic 
markers (sil genes) as the only predictor of the extent to which microorganisms 
can survive silver, predominantly underestimates the precise survival capacity 
under non-laboratory conditions (Muller, 2018). 
 
If AMR is unchecked, disease treatment will be ineffective affecting human and 
animal survival, agriculture, health care cost, GDP and subsequently 
accelerated mortality. Several countries have reported on the negative impact 
of AMR including the WHO, CDC, ECDC and NDoH, calling for interventions to 
combat and reduce the impact of AMR. These include the need for proper 
antibiotic prescriptions, quantification of antibiotic use per region, education on 
drug usage and alternative therapies. Nanoparticles particularly Ag-NPs have 
been identified as potential antimicrobials to alleviate AMR and possibly replace 
antibiotics. Biological Ag-NPs are used in various industries as described by 
Keat et al. (2015), including the highly sensitive biomedical sector. They are not 
only less costly than antibiotics but offer effective antimicrobial effects against 
various microorganisms attributed by their great properties, already described 
by several studies in this section. 
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CHAPTER 3: Optimisation of reaction parameters for Ag-NP 
synthesis by E. xiangfangensis Pb204 
 
Abstract 
The ability of bacteria to reduce heavy metal ions to nanoparticles can be 
exploited in green chemistry. However, biogenesis often results in the 
production of nanoparticles that vary in size, shape and dispersity. This chapter 
focused on the biogenesis of Ag-NPs using a cell-free extract of E. 
xiangfangensis Pb204 and the optimization of synthesis parameters that would 
result in the production of Ag-NPs of uniform size and shape. An overnight 
culture of E. xiangfangensis Pb204 was added to 1 mM AgNO3 for Ag-NPs 
synthesis. The reaction parameters (pH, temperature and time) were varied and 
the Ag-NPs produced ananalysed and characterised by TEM and EDX. 
Reaction pH affected nanoparticle distribution, shape and size while 
temperature and reaction time had effects mainly on size, nanoparticle quantity 
and reduction rate of metal ions into nanoparticles. Nanoparticles synthesized 
under pH 7, temperature of 37 °C and 24 hours reaction time were stable, small 
uniform-sized, spherical and well distributed. These parameters were 
maintained for all further syntheses of Ag-NPs in the study. 
 
Keywords: Ag-NPs, E. xiangfangensis Pb204, biological synthesis, reaction 
parameters,  
 
3.1 Introduction  
Silver nanoparticles are attractive in various applications because they possess 
remarkable properties which include chemical stability, good conductivity, 
catalytic activity and antimicrobial activity. Silver nanoparticles of different sizes 
and shapes have different characteristics and they are highly toxic to numerous 
microorganisms (Katas et al., 2018). Chemical and physical methods use 
hazardous chemicals during nanoparticles synthesis and tend to consume lots 
of energy (Sharma et al., 2009). Chemically synthesized nanoparticles also 
have adverse effects from chemical residues when used in biomedical 
applications (Shankar et al., 2004; Noruzi et al., 2011). Biosynthesis of metal 
nanoparticles has gained interest because the method is  eco-friendly and cost 
effectiveness (Wei and Qian, 2008).  
 
The ability of bacteria to reduce heavy metal ions makes them an ideal 
candidates for nanoparticle synthesis. It appears that they can be used in 
synthesizing stable nanoparticles by optimizing reaction parameters and 
utilizing suitable bacteria resulting in nanoparticles with uniform size, good 
morphologies and compositions (Iravani, 2014). Nanoparticles synthesized 
extracellularly allow for size and shape control by adjusting the pH, 
temperature, substrate concentration and reaction time (Balakumaran et al., 
2016). Bacillus species have been used to synthesize Ag-NPs with various 
shapes (Vaidyanathan et al., 2010) using naturally occurring reducing agents 




defined size were synthesized in aqueous AgNO3 by P. aeruginosa (Klaus et 
al., 1999). Enterobacter xiangfangensis Pb204 is among bacterial species able 
to synthesize metallic nanoparticles including Ag-NPs (Hiebner, 2016; Ho et al., 
2018). Integrative and Conjugated Elements of E. xiangfangensis Pb204 codes 
for 28 proteins that are involved in the resistance of several metals including 
Cu, Ag and Zn (Ho et al., 2018). Furthermore, it is highly probable that the heavy 
metal resistance pathway encoded in the bacterium ICEs plays a role in metal 
uptake and ultimate reduction to nanoparticles. This chapter aimed to 
determine a set of reaction parameters that resulted in the biosynthesis of 




3.2.1 Culturing of E. xiangfangensis Pb204 
A glycerol stock of the bacterium E. xiangfangensis Pb204 previously isolated 
from an acid mine in the West Rand, Gauteng (26°06'26.8"S 27°43'20.2"E), 
was inoculated into Luria-Bertani (LB) broth (Sigma, USA) and incubated 
overnight at 37 ⁰C in a shaking (200 rpm) incubator (Labcon, USA) as a pre-
inoculum. The pre-inoculum was further inoculated at a ratio of 1:100 (v/v) into 
LB broth for biomass accumulation. The culture was incubated for 24 hours at 
37 ⁰C on a continuous shaking incubator (Labcon, USA). Thereafter, the cells 
were harvested by centrifuging at 5000 x g for 15 minutes at 25 ⁰C using a 
Multifuge XIR centrifuge (ThermoFischer, Germany). The cells were discarded 
while the supernatant identified as the cell free extract was used downstream. 
 
The bacterial culture was propagated throughout the study using the same 
culture conditions as described above, by inoculating glycerol stock into LB 
broth. Freshly propagated cultures were maintained in glycerol stocks prepared 
by adding 700 µl of bacterial culture to 300 µl of sterile 100% glycerol (Sigma, 
USA). The stock cultures were maintained at -20 ⁰C until required for biomass 
accumulation. 
 
3.2.2 Extracellular synthesis of Ag-NPs 
The cell free extract of E. xiangfangensis Pb204 that was prepared as 
described above in section 3.2.1 was centrifuged (Multifuge XIR, 
ThermoFischer, Germany) again at 15000 x g for 15 minutes to pellet any 
remaining cell debris. The supernatant was added to 1 mM AgNO3 (pH 7, 
Sigma, USA) in a 1:1 ratio and incubated (with continuous shaking) at 37 ⁰C for 
72 hours with continuous observations for a colour change from pale yellow to 
brown indicating Ag-NPs formation. An experimental control consisting of the 
cell free extract and sterile distilled water (sdH2O) in a 1:1 (v/v) ratio was treated 
under the same conditions. This was done in duplicates for both Ag-NP 
synthesis and their controls. The morphology, size and distribution of the Ag-
NPs were analysed using TEM coupled with energy dispersive X-ray (EDX) 





3.2.3 pH dependent synthesis of Ag-NPs 
The effect of pH on size, distribution and morphology of Ag-NPs synthesized 
by E.  xiangfangensis Pb204 was investigated by synthesizing the Ag-NPs 
under varying pH conditions. The synthesis was done following the same 
procedure as described in section 3.2.2; however, the pH of the AgNO3 was 
adjusted separately to pH 3, 5, and 9. Experimental controls as described 
previously were also included for each pH variable. Furthermore, the incubation 
period was reduced to 48 hours as Ag-NPs were determined to have been 
synthesized within this period. The resulting Ag-NPs were also characterized 
for size, morphology and distribution using TEM described in section 3.2.5. 
 
3.2.4 Temperature dependent synthesis of Ag-NPs 
The effect of temperature on size, distribution and morphology of E. 
xiangfangensis Pb204 synthesized Ag-NPs was also investigated by 
synthesizing the Ag-NPs under varying temperatures. This was performed at 
the optimum pH determined in section 3.2.3 The same procedure in section 
3.2.2 was followed while the incubation temperature was varied at 25 ⁰C, 30 ⁰C 
and 37 ⁰C and included an experimental control for each variant. After 
determining the optimum temperature and pH, the reaction time was further 
reduced to 24 hours to determine if Ag-NPs could be synthesized within that 
period. 
 
3.2.5 Characterization of Ag-NPs using TEM coupled with EDX 
To characterize nanoparticles using TEM (JEM-2100, Jeol, Japan) operated at 
20 kV, 10 µl of the sample was drop-cast on to a holey carbon-coated 200 mesh 
copper TEM grid (SPA, USA) and then dried overnight in a desiccator. 
Following desiccation, the sample was analyzed for size, shape and distribution 
at Spectrum (UJ). Image J Image Processing and analysis software (NIH, USA) 
was used to determine the size of the nanoparticles. EDX spectrum (JEM-2100, 
Jeol, Japan) was used for elemental analysis. 
 
3.3 Results and discussion 
Silver nanoparticles cytotoxicity has been used widely in food and healthcare 
industries (Sharma et al., 2009). For instance, bandages coated with Ag-NPs 
can kill harmful microorganisms and allow better healing at the injured tissue 
(Lee and Jun, 2019). Furthermore, using Ag-NPs in food packaging prevents 
contamination allowing food to last long. One of the major factors that mediate 
numerous biological effects such as DNA damage, cellular uptake, and 
oxidative stress is Ag-NP size. The shape of Ag-NPs can also influence the 
level of particle toxicity and immunological effects in cells (Riaz-Ahmed et al. 
(2017). Aggregated Ag-NPs have lower surface area which limits their 
antimicrobial activity on microbial cells (Ahamed et al., 2008), therefore well 
distributed nanoparticles will exhibit superior antimicrobial effects on microbial 
cells. It is therefore important to consider the reaction parameters used to 





When some microorganisms are incubated with metals, nanoparticles are 
produced as a result of detoxifying metal ions by either reduction or precipitation 
of soluble toxic inorganic ions to insoluble non-toxic metal nanoclusters 
(Narayanan and Sakthivel, 2010) such as Ag-NPs. Shkryl et al. (2018) 
synthesized stable Ag-NPs of 10 – 40 nm in size via a green synthesis method 
utilizing LoSilA1-expressing cali extract. Metal reducing S. oneidensis 
incubated with AgNO3 produced stable, nearly monodispersed spherical Ag-
NPs (2 – 11 nm size range) with an average size of 4 ± 1.5 nm (Suresh et al., 
2010). Lactobacillus species have also been reported to synthesize Ag-NPs 
using of AgNO3 (Pugazhenthiran et al., 2009). To achieve desirable 
nanoparticles with respect to morphology, size and dispersity, optimisation of 
reaction parameters such as pH, temperature, and Ag+ concentration is 
important (Sintubin et al., 2009; Suresh et al., 2010; Amaladhas et al., 2012; 
Umadevi et al., 2012). 
 
This chapter focused on the optimisation of reaction parameters, specifically 
pH, temperature and reaction time, in the synthesis of small, spherical and 
uniformly distributed Ag-NPs using the bacterium E. xiangfangensis Pb204. 
The synthesized Ag-NPs were intended for application as an antimicrobial 
treatment for ESKAPE pathogens as discussed in Chapter 4.  
 
3.3.1 Visual confirmation of Ag-NP synthesis 
Colour formation is the first step in the confirmation of nanoparticle formation. 
Biosynthesis of Ag-NPs was achieved by incubation of the cell free extract of 
E. xiangfangensis Pb204 with 1 mM AgNO3 at a 1:1 ratio. A colour change from 
pale yellow to yellow-brown was observed after 24 hours, 48 hours and 72 
hours incubation period. The colour change to light brown/brown occurs due to 
the reduction of silver ions in AgNO3 solution (Poojary et al., 2016), resulting as 
an excitation of surface plasmon vibrations caused by nanoparticles (Ghaffari-
Moghaddam and Hadi-Dabanlou, 2014). The formation of colour change 
depends on incubation time (Rajeshkumar et al., 2014), observed in slight 
colour differences per incubation period. In this study, the colour changed from 
pale yellow to yellow-brown increasing in intensity as incubation time was 
prolonged. This suggested a proportional relationship between the reaction 
time and colour intensity which correlates to an increase in concentration of Ag-
NPs formed over time. Silver nanoparticles incubated for 72 hours had higher 
colour intensity compared to Ag-NPs incubated for 48 hours and 24 hours. As 
expected, no colour formation was observed for control reactions (culture 
supernatant + sdH2O) due to the absence of AgNO3 in which silver ions are 
usually reduced to metal nanoparticles.  
 
3.3.2 Characterization of Ag-NPs using TEM  
To determine the shape and morphology of the nanoparticles, TEM was used. 
TEM provides crucial information such as overall particle size, shape, 
distribution, etc. (Chaudhuri and Paria, 2012). TEM analysis were done for Ag-




hours. The distribution of the nanoparticles as shown in figure 3.1 appears to 
be variable with the shape clearly observed as spherical. The Ag-NPs ranged 
in size from 4 – 36 nm Ag-NPs with an average of 16.7 ± 9 nm as determined 
by Image J analysis (figure 3.2).  
 
 
Figure 3.1. TEM image of Ag-NPs synthesized by E. xiangfangensis Pb204. 
The image shows spherical Ag-NPs of variable size and distribution formed 
when the cell free extract of E. xiangfangensis Pb204 was incubated with 1 mM 
AgNO3 at 37 ⁰C for 72 hours. Arrows indicate Ag-NPs of different sizes; green 
displaying the smallest Ag-NPs produced and orange the larger ones. 
 
Figure 3.2. Histogram showing Ag-NPs size distribution when the cell free 



























72 hours.  The average particle size of 16.7 ± 9 nm was determined using Image 
J Software analysis tool.  
 
From figure 3.1, the majority of the Ag-NPs appear evenly dispersed with no 
aggregation. This is due to the stabilization of the nanoparticles by capping 
agents possibly being proteins secreted by the bacterium (Ahmad et al., 2003; 
Saifuddin et al., 2009). Uniform distribution is crucial in nanoparticle synthesis, 
since many nanoparticle have insufficient stability during preparations due to 
aggregation has somewhat delayed the development of commercial 
nanomaterial application (Saifuddin et al., 2009). Image J Software (figure 3.2) 
was used to determine size distribution of the Ag-NPs. They were confirmed to 
range between 4 – 36 nm with a mean diameter of 16,7 ± 9 nm. Majority of the 
Ag-NPs were 20 nm in size followed by particles of 8 nm. These were not the 
desired Ag-NPs targeted in this study because they had a large size variation 
and were not evenly distributed with low yield which may affect their 
antimicrobial activity. Gliga et al. (2014) reported that variation in size influences 
the cytotoxicity of Ag-NPs. Several studies (Carlson et al., 2008; Asharani et al. 
2009; Yasin et al., 2013) suggest that small Ag-NPs induce greater cytotoxicity, 
with enhanced penetration abilities against plasma membrane of the cells 
(Braydich-stolle et al., 2010). It was therefore anticipated that with the 
optimisation of pH and temperature, Ag-NPs would be improved in terms of size 
and yield. The Ag-NPs were further characterised using EDX to confirm their 
elemental nature. 
 
3.3.3 Characterization of Ag-NPs by EDX 
Energy dispersive X-Ray spectroscopy is a tool used to characterise elements 
present in a sample. The technique characterizes materials in terms of their 
purity and stoichiometry, relying on a principle that unique atom structures will 
have unique X-ray emission spectrum (Khatua and Das, 2020). In figure 3.3 
below, peaks are observed for carbon (C), silver (Ag) and copper (Cu) in 
different regions.  The grids used to analyse the sample are made of Cu and 






Figure 3.3. EDX image of Ag-NPs produced by E. xiangfangensis Pb204 
showing an Ag peak at around 3 keV along with other elements (Cu and C) 
originating from the grids used during analysis. 
 
Silver nanoparticle formation is confirmed by the presence of a peak in the silver 
region (Kalimuthu et al., 2008). Analysis of the particles from the present study 
indicated a prominent Ag peak roughly around 3 keV confirming Ag-NPs 
synthesis (figure 3.3). A peak at approximately 3 keV is typical for Ag-NPs due 
to surface plasmon resonance (Magudapathy et al., 2001).  
 
3.3.4 Effect of pH on particle size, shape and distribution of Ag-NPs 
Smaller Ag-NPs with definite shape and good distribution have been shown to 
exhibit greater antimicrobial activity compared to larger and agglomerated 
particles. Riaz-Ahmed et al. (2017) states that changes in Ag-NPs 
characteristics (size, shape, surface chemistry and aggregate propensity) have 
an effect on cellular uptake and cytotoxicity of the Ag-NPs. Furthermore, small 
Ag-NPs have been proven to possess superior toxicity, cell permeation and 
inflammatory effects over larger Ag-NPs. Reaction pH can significantly alter the 
electrical charges of biomolecules which could affect their capping and 
stabilizing agents and subsequently nanoparticle growth (Khalil et al., 2014). 
Furthermore, in basic pH flocculation of Ag-NPs decreases significantly 
resulting in decreased aggregation of nanoparticles compared to acidic pH 
state. The effects of pH on the size of particles is dependent mainly on the 
reaction mechanisms involved. Hence a favourable pH is highly desirable to 
control the synthesis reaction (Chaudhuri and Paria, 2012) and subsequently 
yield particles suited to a particular application.  
 
To determine if pH exerts any influence on the shape and size of Ag-NPs 
synthesized by E. xiangfangensis Pb204, a set of different reaction pH (3, 5, 7 
and 9) were studied. The TEM images shown in figure 3.4 represent the effects 
that each pH condition had on the nanoparticles produced after synthesis at 37 






Figure 3. 4. Silver nanoparticles produced under different pH conditions when 
the cell free extract of E. xiangfangensis Pb204 was incubated with 1 mM 
AgNO3 at 37 ⁰C for 48 hours. TEM images at 100 nm scale represent Ag-NPs 
synthesized at (A) pH 3, (B) pH 5, (C) pH 7 and (D) pH 9. Nanoparticles 
produced under acidic conditions had no definite shape with large variation in 
size. At a pH of 7, Ag-NPs appear well distributed with smaller size range and 
no agglomeration, while agglomeration of Ag-NPs was evident at an alkaline 
pH of 9. 
 
From the TEM micrographs, agglomerated nanoparticles can clearly be seen 
in figures 3.4A (pH 3), B (pH 5) and D (pH 9) with the exception of figure 3.4C 
(pH 7) where little/no agglomeration is observed. In a study by Balakumaran et 
al. (2016), Ag-NPs produced by Aspergillus terreus at pH 3 and 4 were 
agglomerated while Ag-NPs formed at pH 7 were monodispersed and stable. 
The little agglomeration observed in figure 3.4C could be as a result of 
insufficient mixing of the sample before being drop cast onto the TEM grid and 
appears to be limited to the larger sized particles in the preparation. Vippola et 
al. (2009) stated that the agglomeration process might be affected by pH, 
electrolyte or salt content, and composition of proteins in the culture media. The 
high surface area of Ag-NPs also have an effect in their high agglomeration 
status in culture media (Bae et al., 2013). Silver nanoparticles with high extent 
of agglomeration are less effective in inducing cytotoxicity effects in different 







Some previous studies (Chaudhuri and Paria, 2012; Khalil et al., 2014; Poojary 
et al., 2016) have reported that pH also plays a role in controlling shape and 
size during  nanoparticle synthesis. This is also evident from figure 3.4 where 
the nanoparticles produced under the different pH conditions in the study varied 
in size. A definite trend in size was not obvious from the results but the smallest 
Ag-NPs were produced at a pH ≤ 7. Nanoparticles produced at pH 3 ranged 
between 6 nm and 34 nm in size (figure 3.4A) which was similar to that of 6 − 
30 nm at a pH of 7 (figure 3.4C). However, a higher degree of particle 
agglomeration is observed at pH 3 as discussed earlier. A reaction pH of 5 
yielded Ag-NPs with the largest variation in size from 6 nm to 61 nm. This 
correlates to the presence of large agglomerates visible in figure 3.4B. While 
the Ag-NPs synthesized at alkaline pH (9) were distributed over a smaller size 
range of 11 − 37 nm, the aggregation of these particles may affect their 
antimicrobial activity. In a study by Lok et al. (2006), Ag-NPs lost their 
antibacterial effect due to aggregation, however, antibacterial effect was 
restored by complexation of the nanoparticles with albumin which stabilized the 
Ag-NPs. Lankoff et al. (2012), studied the effects of aggregated Ag-NPs, 
revealing that highly aggregated nanoparticles are less effective on cellular 
level. 
 
Several studies have investigated the effect of Ag-NP size on different cells and 
they have concluded that smaller particles can induce greater cytotoxicity 
(Elechiguerra et al., 2005; Liu et al., 2010; Lankoff et al., 2012; Akter et al. 
2018). This can be corroborated by a study in which Morones et al., (2005) 
determined that only Ag-NPs of 1 − 10 nm had inhibitory effects on the growth 
of Gram-negative bacteria by disrupting cell membrane functions, penetrating 
into the cells and damaging the DNA.  Most of the nanoparticles in this study 
appear to be spherical particularly those in figure 3.4 C and D, with some being 
asymmetrical (figure 3.4 A and B), which may affect their antimicrobial activity. 
This is because the cytotoxicity of Ag-NPs is influenced by factors such as size 
(Braydich-Stolle et al., 2010; Gliga et al., 2014), shape (Riaz-Ahmed et al. 2017; 
Akter et al., 2018), aggregation (Lankoff et al., 2012) and concentration of Ag+ 
(Park et al., 2010). However, there is insufficient data from studies to obtain a 
concrete idea on the complete cytotoxicity of Ag-NPs and their mechanism of 
toxicity (Akter et al., 2018). After careful consideration, a reaction pH of 7 was 
used in subsequent syntheses due to the desirable nature (shape, size and 
distribution) of the nanoparticles produced under these conditions.  
 
3.3.5 Effect of temperature and reaction time on particle size, shape and 
distribution of Ag-NPs 
All syntheses of Ag-NPs using the cell free extract of E. xiangfangensis Pb204 
in this study were previously performed at 37 oC. The effects of temperature on 
the characteristics of Ag-NPs were investigated by further varying the reaction 
temperature at 25 ⁰C and 30 ⁰C while maintaining a reaction pH of 7 and 
reaction time of 48 hours. Only a few studies have reported on the effect of 




This may be due to the ability to chemically synthesize nanoparticles in 
reactions conducted at temperatures ranging from room temperature (Chahar 
et al., 2018) to around 100 ⁰C (Tran et al., 2013) suggesting a similar versatility 
in biosynthesis. The size of nanoparticles has been reported to decrease as the 
temperature is increased (Fayaz et al., 2010; Liu et al., 2017). Khalil et al. 
(2014) synthesized small sized (20 – 25 nm) nanoparticles using olive leaf 
extract, where they increased the reaction temperature, leading to rapid 
reduction of Ag+ ions and the subsequent homogeneous nucleation of silver 
nuclei.  
 
In the current study, Ag-NPs produced at 37 ⁰C within a period of 48 hours had 
good morphology, small uniform size and spherical shape as seen in figure 3.4 
C (section 3.3.4). When the temperature was set to 25 ⁰C, no particles were 
obtained indicating that the reaction did not proceed or did so very slowly over 
48 hours resulting in too low a yield for visualisation by colour or TEM. The slow 
rate of Ag-NP synthesis at room temperature may be accelerated by increasing 
the reaction temperature (Khalil et al., 2014). Figure 3.5 represents Ag-NPs 
synthesized at 30 ⁰C with continuous shaking over a 48 hour incubation period. 
The image shows low yield of Ag-NPs likely to be spherically shaped. 
 
 
Figure 3. 5. TEM image of Ag-NPs produced using the cell free extract of E. 
xiangfangensis Pb204 in the presence of 1 mM AgNO3 (pH 7) at 30 ⁰C for 48 
hours. A low Ag-NP concentration was observed. 
 
Increasing the reaction temperature from 25 oC to 30 oC did increase the rate 
at which Ag-NPs were made. This was evident from the visualisation of colour 
change and TEM results above (figure 3.5). An increase in the reaction 
temperature has been reported to result in the rapid biosynthesis of 
nanoparticles (Gurunathan et al., 2009; Deepak et al., 2011; Chaudhuri and 
Paria, 2012; Khalil et al., 2014). Although, the low yield of Ag-NPs suggests 
that at 30 oC, the rate at which Ag+ ions are reduced is still slow. When 




synthesis to proceed at 37 ⁰C for the same length of time increased the yield of 
Ag-NPs while maintaining their spherical shape. Based on these results, the 
reaction time under the same conditions (1 mM AgNO3, pH 7, 37 oC) was further 
reduced to 24 hours to evaluate how/if the nanoparticles would be affected. As 
shown in figure 3.6 differences in the Ag-NPs synthesized within 24 hours 
compared to 48 hours were observed. 
 
 
Figure 3. 6. TEM image of Ag-NPs produced using the cell free extract of E. 
xiangfangensis Pb204 in the presence of 1 mM AgNO3 (pH 7) at 37 ⁰C for 24 
hours. Uniform sized spherical Ag-NPs with a size range of 3 – 15 nm were 
observed. 
 
Comparing the results above with those synthesized at 48 hours under the 
same conditions, a longer reaction time resulted in an increase in particle size. 
Using Image J Software for measurement analysis, the Ag-NPs produced after 
24 hours, ranged in size from 3 – 15 nm (average size of 7.80 ± 3.62 nm). 
Nanoparticles synthesized over 72 hours of reaction time had a wider size 
range of 4 – 36 nm (figure 3.1, section 3.3.2). This could be as a result of 
prolonged synthesis which enables the continued reduction of Ag+ resulting in 
larger particles.  Additionally, the uniform distribution of spherical Ag-NPs within 
this smaller size range can be observed in figure 3.6 suggesting that large 




The study set to establish a set of reaction parameters for the production of 




of optimization. Biological synthesis of Ag-NPs has been investigated by many 
studies including the current one with an aim to establish uniform-sized, 
symmetrical shapes and good distribution of the nanoparticles. Silver 
nanoparticles are widely utilized in modern technology, however, there is still 
little understanding on their biological activity. Furthermore, several factors that 
include size, aggregation and agglomeration propensity, treatment duration 
plays a role in effectiveness and possibly safety of Ag-NP-coated medical 
devices, antimicrobial therapy and other application in which Ag-NPs are used. 
The optimum reaction parameters were established and determined to be a pH 
condition of 7, reaction temperature of 37 ⁰C and a reaction time of 24 hours, in 
this study, when E. xiangfangensis Pb204 is used to synthesis Ag-NPs. The 
Ag-NPs produced under these reaction parameters were small uniform-sized, 
spherical shaped particles with good distribution; characteristics which are 
essential for effective antimicrobial activity. 
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Chapter 4: Comparing the antimicrobial activity of biosynthesized 
Ag-NPs with antibiotics used to treat ESKAPE pathogens. 
 
Abstract 
The ability of bacteria to acquire resistance genes has rendered most antibiotics 
ineffective. This may present Ag-NPs as a favourable alternative in fighting 
bacteria resistant to antibiotics. This chapter aimed to establish the 
antimicrobial activity of Ag-NPs against eight bacterial isolates that included the 
ESKAPE pathogens. The effect of Ag-NPs on E. coli, P. aeruginosa, S. aureus, 
A. baumannii, E. faecium, K. pneumoniae, E. cloacae and V. cholerae was 
determined by monitoring their growth spectrophotometrically in the presence 
of 0.1, 0.25, 0.5 and 1 mM as-prepared Ag-NPs. In addition, the activity of 
antibiotics used to treat these bacteria was tested using the Kirby-Bauer 
method where zones of inhibition were measured after 24 and 48 hours of 
incubation. Silver nanoparticles at lower concentrations of 0.1 and 0.25 mM did 
not exhibit any effect on all the bacterial strains tested. However, at 0.5 and 1.0 
mM concentrations, antimicrobial activity against all strains was present and 
determined to be largely bacteriostatic. The dose of Ag-NPs required to inhibit 
bacterial growth was higher than that of the antibiotics commonly used to 
control these strains. Nonetheless, antibiotic activity is strain-specific while Ag-
NPs were effective against all eight bacteria.  
 
Keywords: Antibiotics, antimicrobial activity, ESKAPE pathogens, inhibition. 
 
4.1 Introduction 
Many common and yet lifesaving medical procedures rely on antibiotics to 
mitigate the risk of clinical infections (WHO, 2014). However, the misuse of 
antibiotics in clinical medicine has contributed to problems such as 
development of antibacterial resistance, increased health service costs, 
accelerating chronic disease burden and development of side effects (Alumran 
et al., 2012). The bacterial capacity to acquire various antibiotic resistant genes 
continues to increase as more antibiotics are used worldwide (Abushaheen et 
al., 2020). ESKAPE pathogens are a group of multidrug resistant bacteria 
classified as priority pathogens because they are the leading cause of life-
threatening hospital acquired infections (Santajit and Indrawattana, 2016). 
Treating them has been a complex and challenging subject for at least a few 
decades. Consequently, many countries have had to adopt mitigation plans 
such as antimicrobial stewardships and actively seek alternative treatments.  
 
The use of Ag-NPs to treat antibiotic resistant pathogens has been receiving 
much attention. Silver nanoparticles have been tested for their antimicrobial 
activities and proven effective in a number of studies (Choi and Hu, 2008; 
Guzman et al., 2012; Pařil et al., 2017; Jackson and Smith, 2018; Khan et al., 
2020). In this chapter, the antimicrobial activity of the as-synthesized Ag-NPs 
produced using the cell free extract of E. xiangfangensis Pb204 under 




Furthermore, the dosage of Ag-NPs required to inhibit the growth of the 
ESKAPE pathogens was compared to that of the specific antibiotic commonly 
used to treat each pathogen in the group. 
 
4.2 Methodology 
4.2.1 Propagation and maintenance of bacterial isolates 
The bacterial culture was propagated using the same culture conditions as 
described in section 3.2.1 of chapter 3, by inoculating 50 µl of the glycerol stock 
into 4.95 ml LB broth. Then after incubation the culture were maintained in 
glycerol stocks prepared by adding 700 µl of bacterial culture to 300 µl of sterile 
100% glycerol (Sigma, USA). The stock cultures were maintained in a freezer 
at -20 ⁰C temperature until required for biomass accumulation. The bacterial 
isolates (E. coli, P. aeruginosa, S. aureus, A. baumannii, E. faecium, K. 
pneumoniae, E. cloacae and V. cholerae) were obtained from the Water and 
Health Research Centre (University of Johannesburg, South Africa). 
 
4.2.2 Antibiotic susceptibility test of the bacterial isolates 
A total of six antibiotics, meropenem, ampicillin, cloxacillin, ciprofloxacin, 
vancomycin and combination-type penicillin (amoxicillin and clavulanic acid) 
(Mast Laboratories, UK), at different doses were tested for their activity on the 
eight pathogenic strains used in this study. Pure cultures of each bacterial strain 
were prepared as indicated in section 4.2.1 using the culture conditions 
described in section 3.2.1 and standardised by diluting to an OD600 of 1.00. One 
hundred microliters of a standardised strain was spread evenly on Mueller-
Hinton agar (Sigma, USA) plates and discs impregnated with the specific test 
antibiotic were placed on the plates. This was done in triplicate for each 
antibiotic. The plates were then incubated at 35 ⁰C for 48 hours.  
 
The zones of inhibition were measured with a ruler in mm and the triplicate 
measurements were averaged. Clinical Laboratory Standards Institute guiding 
document M100 Performance Standards for Antimicrobial Susceptibility 
Testing (27th edition,2017) was used as a reference to determine whether the 
bacterial strains were susceptible, intermediate or resistant to the antibiotics 
where applicable. 
 
4.2.3 Growth of bacterial pathogens in the presence of Ag-NPs 
Silver nanoparticles were tested for their antimicrobial activity against the eight 
bacterial strains described in section 4.2.1 above. This was performed by 
assessing the growth of each strain in the presence of different concentrations 
of Ag-NPs using 96-well microplates (Thermo Fisher Scientific, UK). Overnight 
cultures of each of the above strains were diluted in LB Broth (Sigma, USA) to 
an OD600 of 1.00. A stock solution of 50 mM Ag-NPs was used to dilute the 
particles to the final desired concentration. Each designated well consisted of 
a total volume of 200 µl made up of 10 µl of a specific bacterium and Ag-NPs 
at a final concentration of either 0.1 mM, 0.25 mM, 0.5 mM or 1.0 mM diluted in 




the Ag-NPs, growth inhibition of each strain by 1 mM AgNO3 was also 
evaluated. A growth control comprising only the bacterium in LB broth (Sigma, 
USA) was included for each strain. Each variable including the controls were 
tested in duplicate for all bacterial strains as shown in figure 4.1 below. The 96-
well microplate was loaded into an xMark Microplate absorbance 
spectrophotometer (Bio-Rad, USA) for incubation. 
 
Figure 4.1. Experimental set up of the microplate used for antimicrobial assay 
of Ag-NPs and AgNO3 against the eight bacterial pathogens over a period of 
24 hours incubated in an xMark Microplate absorbance spectrophotometer. 
 
With the use of Microplate Manager® 6 Software (Bio-Rad, USA), the xMark 
Microplate absorbance spectrophotometer was set to shake continuously using 
orbital mixing with medium speed at 35 ⁰C. Absorbance readings (duplicate) 
were taken over 24 hours with a 2 hour reading interval in a single optical 
density of 600 nm (OD600) in kinetic mode and used to plot growth curves for 
each bacterial strain.    
 
4.3 Results and discussion 
ESKAPE pathogens are the leading cause of untreatable infections due to their 
widespread drug resistance. This prevalence of AMR can contribute to the 
emergence of a post-antibiotic era in which minor injuries and common 
infections becomes a leading cause of death (Alam et al., 2019). Therefore, 
implementation of effective policies and programs through collaboration of 
multiple stakeholders is necessary to manage this crisis (WHO, 2016). The gap 
between new antimicrobial discovery and development of resistance highlights 
the need to focus on natural antimicrobial compounds (Varela and Kumar, 
2019), for effective drug development. However, numerous compounds 
identified as potential antibacterials by in vitro studies are yet to reach clinical 
application owing to several drawbacks such as economic considerations and 
regulatory procedures involved in drug testing and approval for clinical use 




identified as potential replacements for traditional antibiotics as they continue 
to fail repeatedly (Zaidi et al., 2017). Antimicrobial nanoparticles offer targeted 
therapy via specific accumulation, improved solubility, controlled drug release 
and broad therapeutic index (Huh and Kwon, 2011).  
 
Nanoparticles, particularly Ag-NPs are the most widely studied due to their 
greater antimicrobial activities and ability to kill bacteria using different 
mechanisms (Zaidi et al., 2017), making it difficult for microbes to develop 
resistance against them (Rai et al., 2012). Furthermore, combining 
nanoparticles such as Ag-NPs with antibiotics may also enhance antimicrobial 
activity and possibly subjugate resistance in antibiotics (Huh and Kwon, 2011). 
In this study, Ag-NPs in the range of 3 – 15 nm in size were produced using the 
cell free extract of E. xiangfangensis Pb204 and evaluated for their antimicrobial 
activity against ESKAPE pathogens and two other clinically relevant bacterial 
water-borne pathogens: V. cholerae and E. coli. 
 
4.3.1 Antibiotic profile of the pathogenic strains 
Almost all diseases are treated with antibiotics as the first line drugs to combat 
and fight infections. However, misusing antibiotics has led to rapid development 
of resistance genes by many pathogenic strains. In this study, six antibiotics 
commonly used to treat bacterial infections were selected and tested against 
eight pathogenic strains of bacteria. Among those eight, six are classified as 
ESKAPE pathogens known to be the cause of most common infections such 
as UTIs and life-threatening diseases such as pneumonia. The activity of test 
antibiotics against individual pathogens was evaluated in triplicate after 24 and 
48 hour incubation on Mueller-Hinton agar at 35 ⁰C. The CLSI guiding 
document (M100, 27th edition of 2017) was used to classify organisms as 
susceptible (S), susceptible-dose dependent (SSD), intermediate (I), resistant 
(I) or nonsusceptible (NS) based on zone diameter value for disk diffusion 
inhibition. Table 4.1. is an antibiogram detailing the results obtained for each 
pathogenic strain tested in the study. Where  data was unavailable  to classify 
strains as either S, I  or R, the discussion of their antibiotic profiles is based on 























acid (20/10 µg) 
E. faecium 24  0 (R)2 27 ± 1.5 (S) 0 (R) 13 ± 0.6 (R) 22 ± 2.0 (S) 30 ± 1.2 
48  0 (R) 29 ± 1.5 (S) 0 (R) 13 ± 1.5 (R) 20 ± 0.6 (S) 28 ± 1.0 
S. aureus 24  30 ± 1.5 16 ± 0.6 (R) 0 (R) 25 ± 0.6 (S) 14 ± 0.6 15 ± 1.2 
48  27 ± 0.6 15 ± 1.0 (R) 0 (R) 24 ± 0.6 (S) 15 ± 1.0 13 ± 0.6 
K. 
pneumoniae 
24  18 ± 1.7 (R) 0 (R) 0 (R) 19 ± 1.5 (I) −3 10 ± 0 (R) 
48  19 ± 1.5 (R) 0 (R) 0 (R) 18 ± 2.1 (I) − 10 ± 0 (R) 
A. baumannii 24  16 ± 0.6 (I) 32 ± 1.5 0 (R) 16 ± 1.5 (I) 18 ± 1.7 30 ± 1.0 
48  16 ± 1.5 (I) 31 ± 1.2 0 (R) 15 ± 1.2 (R) 18 ± 2.1 30 ± 1.2 
P. aeruginosa 24  22 ± 1.2 (S) 0 (R) 0 (R) 30 ± 1.0 (S) 13 ± 1.5 0 (R) 
48  20 ± 1.5 (S) 0 (R) 0 (R) 31 ± 1.5 (S) 0 (R)  0 (R) 
E. cloacae 24  21 ± 1.2 (I) − 0 (R) 18 ± 1.2 (I) − 17 ± 0.6 (I) 
48  20 ± 1.0 (I) − 0 (R) 18 ± 0.6 (I) − 16 ± 0 (I) 
E. coli 24  19 ± 1.0 (R) 0 (R) 0 (R) 22 ± 0.6 (S) − 14 ± 0.6 (I) 
48  29 ± 1.0 (S) 0 (R) 0 (R) 20 ± 0.6 (I) − 13 ± 0.6 (R) 
V. cholerae 24  20 ± 0.6 21 ± 0 0 (R) 30 ± 1.0 − 17 ± 0 
48  21 ± 1.5 21 ± 0 0 (R) 30 ± 2.0 − 17 ± 0.6 
 
1 Antibiotics differ in dosage due to availability from manufacturer as well as recommended doses from CLSI. 
2 Strains are classified as susceptible (S), resistant (R) or intermediate (I) based on the diameter of the inhibition zones. Where 
data was unavailable, strains are not classified as either of the three. 




Horizontal gene transfer and mutations have been known to be the cause of 
resistance development in ESKAPE pathogens towards most antibiotics. In that 
regard some antibiotics may not be effective against certain bacteria either due 
to the dosage or resistance conferred by the bacteria towards those antibiotics. 
Cloxacillin, a semisynthetic beta-lactam penicillin type antibiotic used in the 
present study at a dosage of 5 µg, had no antimicrobial activity towards all the 
strains tested. The antibiotic is commonly used to treat penicillinase-producing 
staphylococci and penicillin G-sensitive and penicillin G-resistant staphylococci 
but is ineffective against MRSA with no significant effect on gram negative 
bacilli.  Ampicillin and a combination of amoxicillin/clavulanic acid are also 
classes of beta-lactam antibiotics used to treat both Gram-positive and Gram-
negative bacterial infections. The clavulanic acid is included in the combination 
antibiotic to restore the efficacy of amoxicillin against bacteria that produce 
beta-lactamases (Bush and Johnson, 2000; Livermore et al., 2008, Drawz and 
Bonomo, 2010). Both antibiotics were able to inhibit E. faecium and A. 
baumannii while S. aureus, P. aeruginosa and the three Enterobacteriaceae 
species (E. cloacae, E. coli and K. pneumoniae) exhibited resistance. This is 
because these species contain resistance genes such as ESBLs and 
carbapenemases known to be able to destroy chemical structures of beta-
lactam antibiotics (Livermore, 2002; Boucher et al., 2009; Santajit and 
Indrawattana, 2016). The strain of E. coli has a similar behaviour to that of K. 
pneumoniae particularly in the zones measured after 24 hours for both the 
antibiotics. Ramos et al. (2014) reported that the genome of K. pneumoniae 
shows the presence of drug efflux pumps in large numbers similar to those 
observed in E. coli, which may explain their similar behavior when exposed to 
the antibiotics. The two species were also the first to be reported to contain the 
first mobile colistin resistance gene MCR-1 in China in 2015 (Wang et al., 
2018). The resistance by P. aeruginosa can also be attributed to ESBL 
production and the ability to carry other resistance genes such as 
carbapenemases from K. pneumoniae (Santajit and Indrawattana, 2016). 
Although these antibiotics are not used in the treatment of V. cholerae, the 
zones of inhibition obtained suggest some antimicrobial activity by these 
antibiotics due to their mode of action. 
 
Meropenem is a beta-lactam carbapenem that is commonly used against 
bacteria with ESBLs (Mohr III, 2008) and is one of the antibiotics considered to 
treat A. baumannii infections due to its effectivity and safety (Lee et al., 2017). 
However, A. baumannii is a resilient organism that exhibits an exceptional 
ability to develop antibiotic resistance and as such the emergence of 
carbapenem-resistant A. baumannii (CRAB) has been on the rise (Lee et al., 
2017; Isler et al., 2019). The isolate used in the present study exhibited 
intermediate susceptibility suggesting that a higher dose would be required to 
prevent its growth. Intermediate susceptibility to the antibiotic was also 
recorded for E. cloacae. Pseudomonas aeruginosa and E. coli were inhibited 
by meropenem while K. pneumoniae and E. faecium showed resistance; no 




the zones of inhibition (27 mm, 48 h), it may be suggested that meropenem was 
able to act effectively on S. aureus by inhibiting cell wall synthesis. 
 
Antibiotics such as fluoroquinolones exhibit concentration-dependent killing 
while β-lactams and carbapenems follow time-dependent killing kinetics (Cunha 
and Opal, 2020), which is one of the aspects that explain differences in 
antibiotic activity. Ciprofloxacin, a fluoroquinolones class antibiotic that acts by 
inhibiting DNA replication (Etebu and Arikekpar, 2016) through the inhibition of 
DNA topoisomerase and DNA gyrase is frequently used to treat UTIs and 
bacterial pneumonia. It is the most potent fluoroquinolone against gram 
negative bacilli notably P. aeruginosa and Enterobacteriaceae like E. coli 
(Grillon et al., 2016). In agreement with this observation, both P. aeruginosa 
and E. coli were found to be susceptible to the antibiotic while the other 
members of Enterobacteriaceae (E. cloacae and K. pneumonia) exhibited 
intermediate susceptibility using a dose of 5 µg ciprofloxacin. Ciprofloxacin is 
also known to have some effectiveness against gram positives such as was 
evident for S. aureus in this study where a zone of inhibition of 24 mm (48 h) 
was observed. However, it was ineffective against E. faecium.  
 
Vancomycin is commonly used in the treatment of MRSA and enterococci. 
From table 4.1, it is evident that E. faecium is susceptible to a dose of 30 µg of 
vancomycin. Exposure of S. aureus to vancomycin resulted in a zone of 
inhibition that measured 14 mm after 24 hours and 15 mm after 48 hours. The 
CLSI recommends that MIC tests are preferable for determining the 
susceptibility of staphylococci to vancomycin because the disk test is inefficient 
at differentiating between vancomycin-susceptible and vancomycin-
intermediate isolates of S. aureus. Vancomycin resistant S. aureus (VRSA) 
carry the VanA resistance gene and do not show a zone of inhibition around 
the disk (zone = 6 mm) and their identity should be confirmed. Alternatively, 
isolates that show zones of inhibition ≥15 mm may be considered susceptible 
but require further confirmation using an MIC test as they could potentially be 
vancomycin intermediate S. aureus (VISA) strains 
(https://www.cdc.gov/hai/settings/lab/visa_vrsa_lab_detection.html#:~:text=M
ost%20isolates%20of%20S.,In%20contrast%2C%20S). Based on this 
information, it is probable that the isolate used in this study belongs to VISA. 
Acinetobacter baumannii species are intrinsically resistant to vancomycin due 
to the large nature of glycopeptide molecules that cannot penetrate their outer 
membrane. Interestingly, a zone of inhibition of 18 mm resulted from the 
exposure of A. baumannii to vancomycin in this study. A definitive conclusion 
cannot be made as to whether this isolate is susceptible or resistant to 
vancomycin although at present, vancomycin is used in combination with 
meropenem and colistin/polymyxin to treat MDR A. baumannii strains (Wang et 
al., 2019; Shinohara et al., 2019).  
 
The overall findings from the antibiotic profiles suggest that at least one of the 




each ESKAPE pathogen. However, these isolates exhibit MDR to two or more 
of the antibiotics tested. Escherichia coli was susceptible to meropenem and 
ciprofloxacin but was able to resist the penicillin-type antibiotics. While the CLSI 
does not report the breakpoints for V. cholerae with any of the antibiotics tested, 
the zones of inhibition suggest that it could be susceptible to some beta-lactams 
and ciprofloxacin but cloxacillin is unable to inhibit its growth. Moreover, 
cloxacillin was the least effective antibiotic as all eight bacterial pathogens were 
resistant to it. Both vancomycin and some penicillins were able to inhibit the 
growth of the Gram-positive isolates albeit without a distinct pattern. No 
conclusion can be made with regards to the effectiveness of one antibiotic over 
another in treating the Gram-negatives. 
 
4.3.2 Antimicrobial activity of Ag-NPs on the pathogenic strains 
With the use of an xMark Microplate spectrophotometer antimicrobial activity of 
these Ag-NPs was observed. The Ag-NPs appear to be bacteriostatic 
particularly those at 0.5 and 1.0 mM as compared to those at 0.1 and 0.25 mM 
which exerted little to no inhibition on the growth of all the strains tested. As 
already reported in many studies Ag-NPs possess inhibitory effects against 
many microbial agents including viruses, fungi, yeasts and bacteria. Figure 4.2 
below represents the antimicrobial activities of Ag-NPs at 0.1, 0.25, 0.5 and 1.0 
mM concentrations against eight bacterial strains that included six ESKAPE 







Figure 4.2. Antimicrobial activity of AgNO3 and Ag-NPs on eight bacterial strains, with six strains classified as ESKAPE pathogens plus E. 
coli and V. cholerae. Each graph represents antimicrobial activity of Ag-NPs against; (A) E. faecium, (B) S. aureus, (C) K. pneumoniae, (D) 
A. baumannii, (E) P. aeruginosa, (F) E. cloacae, (G) E. coli and (H) V. cholerae. The AgNO3 at 1.0 mM and Ag-NPs at 0.5 and 1.0 mM are 
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From figure 4.2, it can be observed that both 1 mM AgNO3 and Ag-NPs exert 
an inhibitory effect on bacterial growth; but the antimicrobial activity of Ag-NPs 
is dependent on the dosage/concentration. Silver nanoparticles at 0.1 mM (10.8 
µg/ml) and 0.25 mM (27 µg/ml) concentrations were unable to inhibit microbial 
growth of all the bacterial strains. However, the growth rate of all the strains, 
except for E. faecium and A. baumannii, in 0.25 mM Ag-NPs is initially slower 
than that in 0.1 mM Ag-NPs and the control (without Ag), as indicated by the 
exponential growth phase in the growth curves. The longer exponential phase 
in these species at 0.25 mM Ag-NPs compensates for the slower growth rate 
such that by the time stationary phase is reached, the bacterial numbers are 
similar to the control (without Ag) and 0.1 mM Ag-NP cultures. Only P. 
aeruginosa and V. cholerae experienced slightly decreased growth. In the case 
of E. faecium and A. baumannii, both bacteria seemed to favour growth in the 
presence of 0.1 mM and 0.25 mM Ag-NPs with increased numbers compared 
to the LB control that did not contain any Ag. This was unexpected as Ag-NPs 
have been reported to be effective against these strains and their resistant 
derivatives (Khan et al., 2019). However, there was lower growth of E. faecium 
in the presence of 0.25 mM compared to 0.1 mM Ag-NPs which was not 
observed for A. baumannii.   
 
 In contrast to 0.1 and 0.25 mM concentrations, Ag-NPs at 0.5 (53.9 µg/ml) and 
1.0 mM (107.85 µg/ml) concentrations limited the microbial growth significantly 
for all 8 pathogenic strains. An initial increase (~double) in the A600 over the first 
2.5 hours of incubation is evident indicating some replication of bacterial cells 
occurred. However, continued culturing did not result in increased numbers but 
rather a plateau in the growth curves pointing to the Ag-NPs having a 
bacteriostatic effect on these eight pathogenic strains. A similar trend was 
observed when the pathogens were grown in the presence of 1 mM AgNO3. Of 
all eight pathogenic strains, E. faecium behaved somewhat differently to the 
others whereby the growth achieved in the presence of 0.5 and 1 mM Ag-NPs 
was slightly higher than in the presence of 1 mM AgNO3. This could be an 
indication that 1 mM AgNO3 has a better inhibitory effect than the Ag-NPs on 
E. faecium.  
 
In a similar study to the current one, MICs of Ag-NPs were determined to be 
3.125 µg/ml, 1.56 µg/ml and 3.125 µg/ml against E. coli, P. aeruginosa and K. 
pneumoniae, respectively (Shaker and Shaaban, 2017). Krishnaraj et al. 
(2010), tested Ag-NPs biosynthesized using leaf extracts of Acalypha indica 
against E. coli and V. cholerae. Their study established an MIC of 10 µg/ml Ag-
NPs (size range of 20 –30 nm) for E. coli and V. cholerae. The concentration of 
Ag-NPs found to inhibit growth of E. coli and V. cholerae in the present study 
were at a concentration of 53.9 µg/ml (0.5 mM) and 107.85 µg/ml (1 mM) for 
spherical Ag-NPs ranging between 3 – 15 nm in size which is higher than the 
values reported in these studies. The same concentration of Ag-NPs also 
inhibited the growth of the six ESKAPE pathogens. The differences in inhibitory 




related factors due to silver binding components such as microbial biomass and 
proteins (Zhang et al., 2014). In addition, the different inoculum sizes used to 
determine MICs in this study and other studies also contributes to the 
differences observed during antimicrobial activities. For example, Shaker and 
Shaaban (2017) used starting cultures at a concentration of 5 × 106 cells/ml 
compared to this study which used ~ 5 × 108 cells/ml.  
 
Silver solutions have been used since the early 20th century as an antimicrobial 
agent (Concepcion et al., 2007). Utilizing silver as an antimicrobial agent in burn 
care has also been reported (Castellano et al., 2007; Li et al., 2015; Munteanu 
et al., 2016). Ross et al. (2020) demonstrated that nanocrystalline silver-based 
wound dressing had higher antimicrobial activity than high-oxidation silver salts 
and silver-plated nylon.  Silver nanoparticles can induce higher toxic effects 
according to the concentration of dissolved silver (Navarro et al., 2008), 
presumably due to additional effects of particles and agglomeration on cell 
membranes (Lapresta-Fernández et al., 2012), which depends upon factors 
such as media used (Oukarroum et al., 2012), light conditions, organic 
molecules and particle size or nanoparticle coating (Liu et al., 2010; Shi et al., 
2012).  Silver-containing materials have been studied widely due to 
antimicrobial activity of silver on bacteria, viruses and fungi (Banerjee et al., 
2011; Liu et al., 2013; Agnihotri et al., 2014). However, there are concerns on 
the use of bulk silver that may result in the same fate as antibiotics if not 
checked. Beyond the extensive antimicrobial properties of Ag-NPs, using them 
reduces the bulk concentration of silver subsequently avoiding development of 
resistance by microorganisms to silver. Moreover, biologically synthesized Ag-
NPs offer greater antibacterial effects compared to those synthesized using 
chemical methods.  
 
Biosynthesized Ag-NPs displayed greater antimicrobial effects against S. typhi, 
B. cereus and P. aeruginosa compared to chemically synthesized Ag-NPs 
(Chahar et al., 2018). Similar observations were made by Antony et al. (2011) 
when they studied the effects of biosynthesized and chemical synthesized Ag-
NPs against S. aureus, K. pneumoniae, B. subtilis, E. coli, Proteus vulgaris, P. 
aeruginosa and S. typhi. Concerns have been raised with regards to the 
overuse of Ag+ and Ag-NPs which may lead to silver resistance (Percival et al., 
2005; Randall et al., 2015), promote antibiotic resistance via mutations 
(Kaweeteerawat et al., 2017) or horizontal transfer of antibiotic resistance 
genes (Lu et al., 2020). 
 
Taking into consideration the highest dosage of an antibiotic that an individual 
pathogen was susceptible to, the findings reveal that for some bacterial species 
a higher dosage of the specific antibiotic (20-30 µg, section 4.3.1) is needed to 
inhibit growth compared to the concentration of Ag-NPs that were needed to 
yield similar results. Inhibition of growth was achieved at a minimum dosage of 
10.79 µg Ag-NPs. This was true for four out of the eight pathogens tested: E. 





The chapter aimed to establish the antimicrobial activity of Ag-NPs 
biosynthesized by E. xiangfangensis Pb204 and compare it to that of commonly 
used antibiotics to treat clinically important bacterial pathogens. Reports from 
previous studies describe the antimicrobial effect of Ag-NPs against a wide 
range of microorganisms including MDR bacteria that are able to resist 
antibiotics. Biogenic spherical Ag-NPs (produced in this study) ranging in size 
from 3 – 15 nm were effective at inhibiting the growth of all eight pathogens at 
a MIC of 53.9 µg/ml. Moreover, the inhibitory effect was independent of the type 
of pathogenic strain tested against unlike the antibiotics where individual 
bacterial species are only successfully inhibited by a specific antibiotic(s). The 
outcome of whether the antimicrobial activity of Ag-NPs surpasses that of 
antibiotics used in the treatment of the pathogens tested here is inconclusive. 
Nonetheless, it is noteworthy to mention that three of the ESKAPE pathogens 
(E. faecium, A baumannii and E. cloacae) as well as V. cholerae responded 
better to the treatment with Ag-NPs in terms of µg dosage than antibiotics. The 
use of these Ag-NPs as an alternative treatment for clinically important bacterial 
infections is promising in terms of lowering the mortality rate, reducing the cost 
invested in antibiotics which is a heavy burden on the health sector and the 
continued rise in antibiotic resistant microorganisms. 
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Chapter 5: General conclusion and recommendations 
The ability of E. xiangfangensis Pb204 to reduce heavy metals to nanoparticles 
is due to ICEs which codes for proteins involved in various metal resistance 
including silver. Silver has been used as an antimicrobial since the early 20th 
century. With the rise in antimicrobial resistance, silver has played a pivotal role 
in nanoscience lately, from development of silver-containing materials to 
synthesis of nanoparticles. The prevalence of AMR is a tragic phenomenon that 
has resulted in high mortality rate, staggering healthcare expenditure and many 
uncertainties in the world. This research falls among other studies carried out 
to support the use biologically synthesized Ag-NPs as an alternative therapy 
for the treatment of common yet harmful bacterial infections that are 
exacerbated due to AMR. The advantage of biological methods is the use of 
nontoxic molecules such as proteins, naturally secreted by microorganisms 
compared to toxic chemical stabilizers and reducing agents used in chemical 
processes which have negative effects in the environment.  
 
To the best of our knowledge this is the first study that has attempted to optimize 
the reaction parameters for Ag-NPs synthesis by E. xiangfangensis Pb204 
which were tested for their antimicrobial activity against common clinically 
important pathogens. In an effort to reproducibly produce uniformly superior 
and effective Ag-NPs intended for use as antimicrobials, several reaction 
parameters that included pH, temperature and reaction time were optimized. 
Optimisation of the reaction parameters to pH 7, temperature at 37 ⁰C and short 
incubation period of 24 hours during Ag-NP synthesis by E. xiangfangensis 
Pb204 resulted in a high yield of uniformly spherical particles between 3 − 15 
nm in size with a good distribution. At a MIC of 53.9 µg/ml (0.5 mM), these Ag-
NPs were able to inhibit the growth of eight pathogenic strains which included 
six ESKAPE pathogens known for their resistance capacity. The antimicrobial 
activity of Ag-NPs is attributed to their ability to damage and penetrate cell walls 
of microorganisms, followed by the release of ROS that destroys the cells 
nucleic acids and proteins.  
 
Antibiotics are used as first line treatment for almost all infections, which is 
alarming considering the prevalence of AMR against these antibiotics. Five out 
of the six antibiotics were able to inhibit the growth of the bacterial pathogens, 
although some strains were resistant to these antibiotics. For instance, K. 
pneumoniae was resistant to both meropenem (10 µg) and 
amoxicillin/clavulanic acid (20/10 µg). Ciprofloxacin (5 µg) was the most 
effective antibiotic considering its dosage even though E. faecium and A. 
baumannii were resistant to the antibiotic after 48- hour incubation period. 
These antibiotics are used to treat common infections including hospital 
acquired infections such as UTIs, meningitis, pneumonia and diarrhea. It is a 
concern when they are ineffective leading to treatment with more severe drugs 
that are relatively expensive. Antimicrobial resistance is growing at an alarming 
rate, already leading to human mortality, GDP, poverty, healthcare costs and 
livestock output. It is anticipated that by 2050 the GDP and world trade will both 
fall by 1.1% and 3.8% in low impact and high impact AMR scenario, respectively 




ignored, it may lead to medical poverty trap due to its high cost on the 
population and economy. 
 
Silver nanoparticles in the study exhibited similar and consistent antimicrobial 
activity for all eight bacterial pathogens at a MIC of 0.5 mM (10.79 µg, dosage). 
On the other hand, the antibiotics were strain dependent, implying that a 
specific antibiotic will work on specific pathogen or a group of pathogens such 
as Enterobacteriaceae. Normally antibiotics are designed to inhibit the growth 
of certain microorganisms which explains the above observation. For instance, 
ampicillin is one of the major active beta-lactam antibiotics against enterococci, 
able to inhibit the synthesis of its peptidoglycan (Miller et al., 2014). In addition, 
the findings from the study provided evidence of developing resistance in these 
pathogens. At 25 µg dosage, ampicillin was able to inhibit the growth of E. 
faecium whereas S. aureus was resistant to the antibiotic. Furthermore, the 
dosage of this antibiotic was high (25 µg) compared to 10.79 µg of Ag-NPs used 
to inhibit bacterial growth. In a case of resistant E. faecium, particularly VRE, 
the combination of daptomycin and ampicillin have been reported to be effective 
(Sakoulas et al., 2012); however, these measures increase the costs 
associated with treatment. 
 
Alternatively, the use of Ag-NPs in treatment of these pathogens may be 
implemented. In comparison of the two antimicrobials, this study showed that 
for some but not all pathogenic strains tested Ag-NPs are more effective at 
lower dosage compared to the antibiotics. The effect of these nanoparticles is 
in line with many studies conducted to test the antimicrobial of Ag-NPs on 
various microorganisms which were successfully suppressed by Ag-NPs at 
lower concentrations. 
The study did have some limitations in terms of the methodologies used that 
may have influenced the outcomes reported here. Microorganisms produce 
distinct enzymes in different quantities which can exert an effect on the rate of 
nanoparticle synthesis (Haverkamp et al., 2007) and therefore the yield when 
involved in these types of biogenic pathways. In addition, control of biological 
synthesis is more challenging in terms of uniformity and homogeneity when 
compared to chemical synthesis. This could have contributed to size variations 
(in different ratios) each time nanoparticles were prepared even though the 
conditions of synthesis were for the most part optimised. This can have a slight 
effect on antimicrobial properties per batch synthesised. Often sedimentation 
by standard centrifugation can lead to some loss of nanoparticles and does not 
differentiate between different shaped nanoparticles in mixtures. This can be 
limited by using sucrose gradients and high speed centrifugation to separate 
mixtures of nanoparticles into their distinct shapes while concentrating them. 
Disc diffusion method was initially used to test the antimicrobial activity of the 
Ag-NPs with little success. This may be because of the poor diffusion of Ag-
NPs in solid culture media. Nanoparticles do not travel far from the disc to 
physically interact with the bacterial cells (Kourmouli et al., 2018), which may 
explain the lack of inhibition zones observed during the antimicrobial test. To 




culture broth were conducted to evaluate their antimicrobial activity. This 
method of broth dilution is in fact a more accurate technique to establish MICs 
for any antimicrobial agent. Furthermore, a true comparison of Ag-NPs versus 
antibiotics was not feasible due to the difference in methodology used. It is 
therefore recommended that the study be repeated using the dilution method 
to establish the MICs for the antibiotics and that it is extended to evaluate the 
combined use of Ag-NPs and antibiotics in the treatment of these pathogens. 
 
The findings reported here support the continued pursuit of these Ag-NPs as 
an alternative to antibiotic treatment. Using the optimised reaction parameters, 
the production of these Ag-NPs can be scaled up and the knowledge gained 
implemented in the design of an industrial process for their large-scale 
production. Narrowing the MIC for the Ag-NPs can be performed to establish 
an even lower dosage required to prevent growth of the pathogens while more 
accurate broth MICs can be determined for the antibiotics. Since there is no 
evidence supporting the superiority of Ag-NPs over antibiotics or vice versa, it 
is hereby suggested that further testing of the combined use of Ag-NPs with 
antibiotics is advantageous for treating ESKAPE pathogens. This treatment 
strategy could result in enhanced antimicrobial activity, reduced AMR and more 
effective treatment especially against antibiotic resistant strains.  
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